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Society and physicians frequently associate the increase of antibiotic-resistant 
bacteria with the overuse of antibiotics. This proposes a question, “Why use antibiotics to 
fight bacteria and risk resistance, when one could engineer bacteria to target and kill 
infectious bacteria?” Bacteria are often thought of as ‘good’ bacteria (e.g., commensals, 
probiotics) or ‘bad’ bacteria (e.g., pathogens). Synthetic biology enables the augmentation of 
biosynthetic capabilities and retooling of regulatory structures in the creation of cells with 
unprecedented ability to make products. One can also, however, think of the cell as the 
product – a cell that operates in a noisy environment to execute non-native tasks. There have 
been several recent reports of the rewiring of bacterial cells to function as conveyors of 
therapeutics. The engineering and rewiring of the bacteria such as E. coli into ‘smart' bacteria 
potentially allows for a broad range of applications, from the treatment of wounds, the 
elimination of pathogenic strains, to the delivery of vaccines, particularly in the 
gastrointestinal (GI) tract. I have engineered smart bacteria as a therapeutic delivery vehicle 
   
for wound healing in the GI tract. The approach comprises synthetic biology and 
microfluidics for the creation of a biological ‘test track' for ensuring the appropriate design 
and testing of engineered bacteria. Bacterial motility was engineered for response to wound-
generating signals such as hydrogen peroxide. Specifically, we have placed a motility enzyme 
CheZ under the control of the hydrogen-peroxide-responsive oxyR/S gene-promoter pair so 
that the ‘run’ in the tumble and run scheme of bacterial movement is externally regulated. 
These engineered cells exploit pseudotaxis for directional swimming towards hydrogen 
peroxide, a non-native signal. Additionally, the therapeutic enzyme transglutaminase plays an 
important role in the tissue clotting cascade. Microbial transglutaminase can crosslink 
fibrinogen, similar in function to human transglutaminases during the clotting cascade, but 
independently of calcium ions. This allows for a potentially faster, increased wound-healing 
response. By combining microbial transglutaminase expression with controlling motility and 
lysis expression using the OxyR/S system, the ‘smart’ bacteria can potentially swim towards 
and treat at the wound site with subsequent cell lysis. Ultimately, this strategy can lead to 
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Chapter 1: Introduction 
 
1.1 Background 
1.1.1 Bacteria, Hospital Acquired Infections, and the FDA’s Role 
In society over the past few years, not a week went by without the news reporting 
civil unrest or an update on the latest healthcare crisis. Over the past 5 years, the healthcare 
news updates included Zika, Ebola, enterovirus 68, necrotizing fasciitis (flesh-eating 
bacteria), and hospital acquired infections (HAIs), specifically methicillin-resistant 
Staphylococcus aureus (MRSA). Ebola and enterovirus 68 are viruses that cannot be treated 
with antibiotics; however, necrotizing fasciitis and MRSA are two well-known bacterial 
infections because of their increasing difficulty to treat. Researchers and physicians report 
finding an increasing number of necrotizing fasciitis cases with MRSA-origin1. This 
represents one example of the increase in the number of antibiotic-resistant bacteria.  
Society and physicians frequently associate the increase of antibiotic-resistant 
bacteria with the overuse of antibiotics. Therefore, industry and researchers have looked for 
alternatives to antibiotics, such as utilizing a combination of the gut microbiome, probiotics, 
and/or disease-specific engineered probiotics. However, bacterial therapy’s translational 
application is in the infancy stages at the FDA. In 2016, the company Seres entered Phase 2 
clinical testing of its ‘poop pill,’ SER-109 for treatment of Clostridium difficile bacterial 
infection; the treatment process involves taking a stool sample from the patient, extracting 
and purifying 5 to 15 bacterial strains for insertion into the pill, and oral ingestion of the pill 
to restore gut health and cure the infection; however, they failed the Phase 2 clinical trial due 
to the inability to reduce the relative risk of C. diff recurrence, compared to a placebo, up to 





adjusted the development for SER-109 and entered Phase 3 clinical trials2. Other companies 
were or are also seeking FDA approval for gut health restoration and cure of infection3. These 
companies are taking the first steps toward FDA approval of bacterial therapeutics. This 
shows there is promise for expanding bacterial therapy as a conventional and/or alternative 
treatment for bacterial infections and potentially targeted injury-specific or disease-specific 
therapies. 
1.1.2 Relationship Between HAIs, Combat Soldiers Abroad, and Global Health 
Combat soldiers face danger every day they are abroad in combat zones in Iraq or 
Afghanistan; soldiers can see the physical dangers, but they miss the invisible danger – 
viruses, bacteria, and fungi that live in the soil and possibly in their wounds. Wounded 
soldiers’ lives depend on the evacuation speed, surgeon’s ability to properly clean and treat 
the wound, degree of blood loss, and exposure of the wound to infectious microorganisms. 
The microorganisms existing in the soil and found in soldiers’ wounds vary depending on the 
region, climate, and microorganism’s evolution4,5. In order to best protect soldiers from 
losing limbs to infection and amputation, researchers and physicians must understand and 
create libraries of these microorganisms and create treatment plans, especially if the bacterial 
microorganisms have antibiotics resistance. 
In response to the public’s growing concern with infection and antibiotic-resistant 
infection control, the military and Department of Defense are also taking the initiative; 
currently, researchers at the Lawrence Livermore National Laboratory (LLNL) with four 
other research organizations are creating a library to identify and characterize the phenotypic 
and genotypic changes of colonizing and infection E. coli found in Iraq and Afghanistan 
combat zones and soldiers’ wounds from June 2009 to May 20114–6. They developed a novel 





bacterial pathogens. Currently, the standard culture method does not detect a bacterial 
pathogen existing in the infected wound samples they tested. The LLNL’s current library 
contains probes for approximately 3,855 bacteria6. In their findings, the researchers 
frequently classified both the colonizing and infecting isolates as extended-spectrum β-
lactamase (ESBL)-producing E. coli. This gives rise to concern because the majority of ESBL 
infected wounds heal unsuccessfully; even though ESBL infections are associated with 
hospital infections, studies in recent years show an emerging link between ESBL and 
community-acquired infections4. Therefore, by creating a library of infectious and drug-
resistant bacteria’s phenotypes and genotypes, one can quickly identify the infection and 
develop a treatment plan. 
1.2 Synthetic Biology Approach to Therapeutics 
Synthetic biology offers a potential therapeutic alternative to current infection 
treatment methods, considering the rise of antibiotic-resistant bacteria. Synthetic biologists 
construct novel genetic/biological systems through genetic rewiring for use in bacteria to treat 
environmental, energy, and health problems. Recent advances in the field produced bacteria 
containing switches7, amplifiers8,9, oscillators10,11, and genome recombination methods12 to 
create highly specialized bacteria with a variety of biosynthetic abilities, including sense and 
respond phenotypes13,14. By utilizing genetic rewiring, researchers created ‘smart’ bacteria as 
the final product for targeting infectious bacteria; most importantly, these groups created the 
‘smart’ bacteria to target to disease or infection sites and deliver therapeutics using the 
minimal required doses to reduce side effects. One group, Chang et al.14, genetically 
engineered E. coli to sense and kill nearby P. aeruginosa via secretion of pyocin S5 (a killing 
protein specific to the pore-forming activity of P. aeruginosa) in response to its identifying 





oxododecanoyl homoserine lactone); in addition, the bacteria were engineered to later self-
destruct. This example is just one of a few that looks to exploit the natural signaling processes 
that exist in individual bacteria and the methods of rewiring their genetic circuits to produce a 
desired outcome – target and treatment of an infectious disease. 
In combination with the “poop pill” theory addressed in 1.1, one can engineer smart 
bacteria to autonomously target, treat, and lyse at a disease or wound site based on the 
specific density of the bacterial, chemical and/or molecular signals up-regulated at the site; as 
a starting platform, one can encapsulate the bacteria for oral delivery. By genetically rewiring 
bacteria, one can create a new, innovative platform for developing and optimizing spatially-
sensitive and physiologically-relevant disease-targeting bacteria in combination with the 
research community, industry, and the FDA. 
1.3 Global Objective and Hypothesis 
1.3.1 Global Objective 
Soldiers wounded in combat abroad face a multitude of obstacles during the critical 
treatment time, including degree of blood loss, evacuation speed, the military surgeon’s 
ability to completely treat the wound, and the unknown microorganisms that exist in foreign 
soil; these foreign microorganisms include viruses, bacteria, and fungi, all of which affect 
wound treatment and healing time. Diminishing and eliminating these foreign 
microorganisms can be accomplished by using synthetic biology. Specifically, by rewiring 
the parts of the E. coli’s natural genetic circuitry, one can engineer ‘smart’ bacteria to swim 
towards the wound site, dock, and either recruit a second therapeutic bacterial population or 
deliver therapeutics. The type of therapeutic delivery can vary depending on the type of 
wound and type(s) of foreign microorganisms infecting the wound. This proposal will focus 





antibiotic-resistance developing in current types of infections, bacterial therapy would be an 
alternative treatment to antibiotics; one can use ‘smart’ bacteria to target, deliver therapeutic 
aid, and kill infectious bacteria. 
 
Figure 1 – Schematic of engineered bacteria targeting and treating a gastrointestinal wound.  
1.3.2 Hypothesis 
To accomplish all of these objectives for this dissertation, the bacteria’s natural 
genetic circuitry must be re-wired and balanced, not overburdened. I will briefly discuss the 
principles and technologies necessary to genetically engineer and modify the bacteria to 
accomplish the objectives in the latter part of Chapter One. Chapter Two will serve to 
characterize the hydrogen-peroxide (H2O2)-controlled bacterial running, specifically CheZ. 
Chapter Three will focus on characterizing the phenotypic response of the engineered 
motility bacteria to H2O2. For therapeutic purposes, I will express microbial transglutaminase 
(mTG), as opposed to the larger and highly insoluble (in bacteria) recombinant human tissue 
transglutaminase, in the engineered bacteria as a method to speed wound healing; 





Chapter Four. Finally, a lysis system, also under H2O2 control, will be characterized in 
Chapter Five, including whether the therapeutic can be released into the supernatant and 
maintain activity. By combining mTG expression and the other systems with H2O2-controlled 
CheZ motility and lysis, the ‘smart’ bacteria can potentially swim towards, dock, and treat the 
wound site with minimal motility burden from the therapeutic systems expressed. 
 
Figure 2 – Schematic of proposed engineered bacteria. 1. The engineered bacteria synthesize the biotherapeutic 





the engineered bacteria turn on motility. 3. The engineered bacteria target the H2O2 at the wound site for 
antibody-specific docking. 4. The engineered bacteria lyse at the wound site, releasing the biotherapeutic. 
1.4 Hydrogen Peroxide 
1.4.1 Role: Wound Sites 
Researchers have extensively documented the phases of epidermal skin wound 
healing. Immediately after injury occurs, the dynamic wound-healing response starts with a 
blood clot starting to form; once homeostasis occurs15,16, the inflammatory phase begins with 
neutrophils gathering at the wound site for release of bactericidal reactive oxygen species and 
H2O2 to kill bacteria and prevent infection; then, environmental stimuli cue macrophages to 
arrive, phagocytose (eat) foreign particles, and release vascular endothelial growth factor 
(VEGF) to modulate angiogenesis via tissue vascularization growth factors15,17,18. 
Specifically for this proposal, gastrointestinal (GI) epithelial wound healing will 
serve as the model injury/disease state. Naturally, the intestinal epithelial cells form tight and 
adherens junctions to regulate the passive movement of luminal fluid and solutes, passive 
diffusion, and intercellular adhesion; importantly, these cells also allow some non-
pathological gut microbiota access to the immune system, to promote and evolve immune 
tolerance. Recent studies have demonstrated the importance of commensal bacteria activating 
toll-like receptors to inhibit inflammatory responses and maintaining colonic homeostasis19. 
However, injury to the epithelial barriers, especially of the mucosal surfaces of the GI 
system, is found in a number of states; these include pathological states such as inflammatory 
diseases, ischemic events, and also mechanical injury from medical intervention or surgical 
repair19. Injury to the (GI) epithelial lumen lining allows an increased absorption of toxic and 
immunogenic factors, leading to disruption of homeostasis, inflammation, and an 
uncontrolled immune response. Activation of the wound healing response resembles that of 
epidermal skin, including the generation of oxygen free radicals (such as H2O2); however, 





inflammatory process and epithelial surface repair20. Additionally, researchers discovered that 
various regulatory peptides, including growth factors and cytokines, along with novel toll-like 
receptors, particular dietary factors, and gastro-protective agents help regulate intestinal 
wound repair19. 
Mitchison et al.21 conducted one of the key studies for visualizing and linking rapid 
wound detection via a tissue-scale H2O2 pattern in zebrafish larvae; their findings indicate that 
the H2O2 gradient does not rapidly dissipate once the injury occurs. Therefore, the H2O2 
gradient can be used as a signaling molecule for recruiting the engineered smart bacteria to 
the wound site. 
Importantly, initial screens suggest that the H2O2 concentrations investigated here are 
within the reported physiological ranges for eventual deployment at wound sites, potentially 
including those in the GI tract21. Researchers demonstrated in vitro that H2O2 concentrations 
at 0.1-0.5 mM delayed murine fibroblast cell apoptosis for 24-48 hours, with no apoptosis 
below 0.1 mM 22. Notably, in vivo studies conducted in zebrafish, a popular vertebrate model 
system, demonstrated a burst release of H2O2 (0.1-0.2 mM at wound site) to recruit immune 
cells to prevent infection21. Additionally, in vivo mice studies demonstrated and quantified 
that dermal wound H2O2 levels persisted during the immediate inflammatory days (> 200 µM; 
2 days post-wounding) and post-inflammatory days (~150 µM; 5 days post-wounding); when 
the researchers added a topical low-dose H2O2 (1.25 µM/wound) treatment, it increased the 
wound healing response23. Given these initial indications, we performed studies to evaluate 
H2O2 -dependent dynamics of the promoter system, cell growth, and subsequent swimming 
phenotype. Given these initial indications, we performed studies to evaluate H2O2 -dependent 





1.4.2 Role: Disease States 
While this dissertation focuses on using ‘smart’ bacteria to traffic to and treat at a GI 
wound site, broader applications apply. When the dynamic wound-healing process continues 
to evolve and expand without limitations, tumourigenesis begins. Depending on the tumor, 
different tumourigenesis signaling pathways are activated and upregulated; for solid tumors, 
the cancer cells hijack and constitutively upregulate the wound repair signaling pathways. In 
addition, tumor development from wound sites occurs when inflammation does not subside 
when re-epithelization is complete16. By using these upregulated pathways, ‘smart’ bacteria 
can be trafficked to the acidic tumor microenvironment and deliver therapeutics. 
Additionally, GI diseases including inflammatory bowel disease (IBD), ulcerative 
colitis (UC), and Crohn’s disease (CD) cause oxidative stress to the mucosal cells of the GI 
tract; mucosal biopsies taken by Bibloni and colleagues expressed increase in lactobacilli 
compared to healthy biopsies. Some species of Lactobacillus, Streptococcus and 
Enterococcus genera produce substantially high amounts of H2O2, compared to the amount 
released by the immune response24,25. Furthering these studies, Strus et al. sought to elucidate 
the relationship between H2O2 development and the body’s immune response to IBD. They 
reported increased populations of Lactobacillus and Streptococci adherent to the IBD lesions; 
when cultured in vitro, multiple species tested produced a range of 0.3 – 0.6 mM and 0.3 – 
1.8 mM H2O2 over 4 and 24 hours, respectively. They hypothesized that the increase in the 
total populations of these aerobic bacteria but not anaerobes in the studied IBD samples 
indirectly provides evidence of higher oxygen tension present in the inflamed IBD tissues, 
possibly due to the imbalanced anti-oxidative activity of the IBD mucosa25. Specific to our 
study, potential applications and the natural presence of bacteria in the gut microbiome, we 





1.4.3 Using H2O2 as a Genetic Controller 
Bacteria naturally respond to oxidative stressors such as H2O2 and other reactive 
oxygen species (ROS) that are released by eukaryotic cells upon insult such as pathogen 
infection or wound generation. They possess several mechanisms, including the OxyR/S-
mediated response triggered by H2O226–28, for protection against toxicity. 
Eukaryotic/prokaryotic organisms also produce ROS as a byproduct of normal aerobic 
metabolism; thus, they have naturally developed machinery and mechanisms to convert the 
metabolic ROS side products into non-toxic products thereby maintaining homeostasis26,29. At 
physiological levels of H2O2 (~20 nM), OxyR acts as a repressor28,30,31 of oxyS RNA 
transcription. OxyS RNA, in turn, is a global oxidative stress regulator mediating the 
activation or repression of over 40 genes26,29. In the presence of elevated H2O2 levels, changes 
in the oxidation state of OxyR’s sulfhydryl groups at Cys199 and Cys208 promote the 
formation of a disulfide bond26, that, in turn, modulates OxyR’s structural conformation 
leading to subsequent transcriptional activation of many promoters involved in oxidative 
stress regulon32–34, including oxyS26,29 (Figure 3). This structural change, involving oxidation 
and reduction reactions, occurs extremely quickly, at a rate of 9.7 s-1 34. 
 
Figure 3 – OxyR activation. The engineered bacteria tumble when H2O2 is not present. When H2O2 is present, 
H2O2 oxides the sulfhydral groups to form a disulfide bond, thus activating transcription and translation (for 





1.5 Bacterial Motility 
1.5.1 Quorum Sensing-Based Motility 
 In E. coli, quorum sensing (QS) is an organic, complex cell-to-cell communication 
process that regulates and results in pathogenicity, biofilm formation, virulence, and growth, 
and cell motility35–38. In order to understand bacterial motility and population-based behavior, 
researchers studied the QS mechanisms in E. coli and pathogenic bacteria, such as P. 
aeruginosa, to understand the how the bacteria talk to each other using multi-cellular level 
interactions. Briefly, bacteria modulate QS by the synthesis, sensing and uptake of small 
chemical molecules called autoinducers. Using autoinducers, specifically acyl homoserine 
lactones (AHLs), autoinducer-2, and many other universal signals, the bacteria “talk” by 
sending, receiving, and processing different forms of these chemical signals. Through 
“talking,” to either their own species or other bacterial species, bacteria enumerate and 
modulate local bacterial densities to evade the immune host and survive. This leads to the 
phenotypic expression of cell motility and other factors via population-based recruitment. 
Low-density bacterial populations express low amounts of QS molecules. However, as the 
population increases, the amount of QS molecules being expressed and exchanged grows, 
recruiting more bacteria to the site; this yields exponential QS-based growth towards the 
favorable, autoinducer-rich environment35,36. 
1.5.2 Bacterial Motility: Chemotaxis versus Pesudotaxis 
Similar to QS-based motility, chemotaxis is defined as the biased process by which 
bacteria move towards a more favorable chemical environment (either a nutrient or food 
source) or away from a more toxic chemical environment39–41. For E. coli, Brownian motion 
(random movement) and viscous drag physically constrain them; however, using gene 





Brownian motion to a more directional swim. To accomplish this, bacteria alternate the 
rotation of their flagella between clockwise and counterclockwise rotations41. 
Specifically, this dissertation will focus on the CheY/CheZ mechanisms for 
controlling E. coli motility. The cheY gene activation turns the flagella motor in a clockwise 
motion, resulting in a random tumbling motion (Figure 4-a); The cheZ gene activation turns 
the flagella motor in a counter-clockwise motion, resulting in a more directional, biased run41 
(Figure 4-b).  
 
Figure 4 – Bacterial motility. a. CheY activation. Phosphorylated CheY binds to the flagellar motor complex. The 
complex rotates clockwise, resulting in tumbling. b. CheZ activation. CheZ dephosphorylates CheY. CheY unbinds 
from the flagellar motor complex, resulting in counterclockwise rotations and bacterial running. 
Alternatively, to activate directional swimming via CheZ activation, the opposite 
mechanisms occur. First a chemoattractant binds one of five methyl-accepting chemotaxis 
protein (MCP) receptors; this signals the MCP-CheW-CheA tertiary complex in the 
cytoplasm. It allows the MCP to demethylate and CheW (the scaffolding protein) to receive 
chemical stimuli39–41. Dynamically, this also activates CheA, an autokinase, to use ATP to 
autophosphorylate CheB from a specific CheA histidine residue20. In addition, CheZ 
dephosphorylates CheY to balance phosphorylation levels. When paired with methylation and 
phosphorylation of CheB with dephosphorylation of CheY, the tertiary complex becomes an 
inactive kinase. These dynamic reactions result in the flagella motors turning counter-






Figure 5 – CheZ mechanistic activation. 
Researchers have well-documented the mechanisms of activating CheY and CheZ. 
The CheY phosphorylation cascade activates bacteria’s random tumbling motion. For default 
CheY activation, first a chemo-repellant binds one of five methyl-accepting chemotaxis 
protein (MCP) receptors; this signals the MCP-CheW-CheA tertiary complex in the 
cytoplasm. It allows CheR to methylate the MCP, and CheW (the scaffolding protein) to 
receive chemical stimuli39–41. Dynamically, this also activates CheA, an autokinase, to use 
ATP to autophosphorylate a specific CheY aspartate residue from its specific histidine 
residue39. To control phosphorylation levels in the bacteria, CheB is dephosphorylated to 
balance CheY phosphorylation levels. When paired with dephosphorylation of CheA and 
methylation of a specific glutamic acid in the MCP, the tertiary complex becomes an active 
kinase. These dynamic reactions result in the flagella motors turning clockwise, yielding a 






Figure 6 – CheY mechanistic activation. 
 
1.6 Wound Healing: The Clotting Cascade 
1.6.1 Transglutaminase’s Role 
Many approaches to wound treatment exist, from antibiotics and band-aids to 
suturing to skin grafts. However, many different physiological factors play a dynamic role in 
wound healing, as discussed previously in 1.4.1. Human tissue transglutaminase (htTG) plays 
a large role in epithelial wound healing. htTG is a multifunctional protein with catalytic 
functions including peptide crosslinking. htTG is a large protein, ~80 kDa42. Other 
transglutaminase genes serve to stabilize the fibrin clot in homeostasis, serve as a structural 
component of the cytoskeleton, etc42,43. However, overexpression of htTG can lead to disease, 
specifically celiac disease44. In order to express human enzymes in bacteria, the human 
enzyme must be codon-optimized for expression in bacteria. Previous studies conducted by 
Shi et al. found that recombinant htTG2 expressed in bacteria yielded > 90% inactive, 
insoluble rhtTG protein; attempts to optimize expression temperature and pH yielded no 
improvements44. Therefore, due to its extremely low solubility in E. coli, an alternative 





1.6.2 Microbial Transglutaminase: An Alternative and Applicable Approach 
Because of htTG’s large size and folding sensitivity, mTG serves as a comparable 
replacement; possibly due to convergent evolution, mTG shares similar crosslinking 
capabilities expressed by htTG. Additionally, htTG require calcium ions for enzyme 
activation; mTG does not require calcium to activate and has a more robust stability along a 
broad range of pH and temperatures45. 
mTG from Streptomyces mobaraensis (28 kDa) was first studied by Yokoyama et al. 
to its use in food processing for its effective protein crosslinking activity. Specifically, 
transglutaminases catalyze the acyl-transfer reaction between ℇ-amino group of lysine and the 
γ-carboxyamide group of glutamine in proteins. This crosslinking reaction has been tested in 
type I collagen46, type II collagen47, and gelatin hydrogel48–50. More extensive studies 
examined stability and activity across the different hosts and species. Further studies added a 
pro-region to mTG to expand mTG’s solubility and activity across a broader range of 
temperature and pH51. 
Therefore, to limit metabolic burden and increase soluble transglutaminase 
expression, mTG will be used and tested in Chapter 4. By using mTG, as opposed to htTG, 
one can avoid pathogenesis and quicken wound healing by not disrupting htTG homeostasis 
levels. 
1.7 Site-Specific Bacterial Docking 
Site-specific bacterial docking requires antibodies to be displayed on the outer 
surface of E. coli that are disease-specific. Previous studies have engineered proteins on the 
outer surface using well-established phage systems52. Specifically, AIDA-I is a more robust 
system that allows for surface display of enzymes, enzyme inhibitors, and other small 





found in N. gonorrhoeae was first described by Pohlner et al. in 198754; the autotransporter of 
the IgA1 protease-like family consists of a signal peptide at the N terminus, one or more 
domains for transport, and an autotransporter structure at the C terminus. The autotransporter 
domain forms after translocation through the β-sheet barrel within the outer membrane. The 
N-terminally attached passenger protein is translocated to the surface through this porin-like 
barrel54. Maurer et al. optimized AIDA-I, an E. coli adhesin co-expressed with the orfA gene 
for diffuse adherence to HeLa cells, for only efficient surface display and release of soluble 
recombinant proteins52–54.  
Therefore, in Chapter 4, I will discuss using AIDA to surface display Protein G and 
load antibody for site-specific docking; this serves as a reasonable solution to ensure that the 
engineered therapeutic bacteria remain at the theoretical GI wound site. 
1.8 E. coli Lysis Protein E7 
 Naturally, bacteria do not secrete protein. However, to overcome this issue for 
protein bio-production in E. coli, Saeidi et al. designed a synthetic genetic circuit using 
quorum sensing and the lytic protein colicin E7, native to colicin-producing E. coli, to kill the 
engineered bacteria and release the biotherapeutic14. E-group colicins are a group of plasmid-
borne bacteriocins that exhibit antibiotic-like inhibition of bacterial growth55–57. While less 
studied than other E-group , E7 lysis causes inner membrane damage and possibly activates 
outer membrane phospholipase A to permeabilize the outer membrane via lysophospholipid 
formations14,58. Since the E7 lysis protein is extremely small and native to E. coli14,56,58, it can 
be easily utilized as a dual-purpose protein – ensure biotherapeutic protein release and 





Chapter 2: Bacterial Response to H2O2 
 
2.1 Introduction 
Synthetic biologists construct innovative genetic/biological systems to treat 
environmental, energy, and health problems. Many systems employ rewired cells for non-
native product synthesis, while a few have employed the rewired cells as ‘smart’ devices with 
programmable function. Building on the latter, we developed a genetic construct to control 
and direct bacterial motility towards H2O2, one of the body’s immune response signaling 
molecules. A motivation for this work is the creation of cells that can target and 
autonomously treat disease, the latter signaled by H2O2 release. Bacteria naturally move 
towards a variety of molecular cues (e.g., nutrients) in the process of chemotaxis. In this 
work, we engineered bacteria to recognize and move towards H2O2, a non-native 
chemoattractant and potential toxin. The system exploits oxyRS, the native oxidative stress 
regulon of E. coli. 
Bacteria naturally respond to oxidative stressors such as H2O2 and other ROS 
molecules that are released by eukaryotic cells upon insult such as pathogen infection or 
wound generation. They possess several mechanisms, including the OxyR/S-mediated 
response triggered by H2O226,27,59, for protection against toxicity. Eukaryotic and prokaryotic 
organisms also produce ROS as a byproduct of normal aerobic metabolism; thus, they have 
naturally developed machinery and mechanisms to convert the metabolic ROS side products 
into non-toxic products thereby maintaining homeostasis 26,29. At physiological levels of H2O2 
(~20 nM), OxyR acts as a repressor of oxyS RNA transcription in E. coli 30,31,59. OxyS RNA, 
in turn, is a global oxidative stress regulator mediating the activation or repression of over 40 





sulfhydryl groups at Cys199 and Cys208 promote the formation of a disulfide bond 26, that, in 
turn, modulates OxyR’s structural conformation leading to subsequent transcriptional 
activation of many promoters involved in oxidative stress regulon 30,33,34. These include oxyS 
29 (Figure 7). This structural change, involving oxidation and reduction reactions, occurs 
extremely quickly, at a rate of 9.7 s-1 34. 
 
Figure 7 - H2O2-controlled bacterial motility. a. Left. CheY activation. Phosphorylated CheY binds to the 
flagellar motor complex, counterclockwise rotation resulting in tumbling. Right. CheZ activation and bacterial 
design. H2O2 modulates OxyR, enabling oxyS RNA activation of CheZ. CheZ dephosphorylates CheY, which is 
released from the flagellar motor resulting in clockwise rotation and a run. c. CheZ-CheY ratio controls 
run/tumble. As the ratio of CheZ to CheY increases (x axis), the bacteria decreases tumbling time and increases 
running time. In native E. coli, the ratio of CheY:CheZ expression is approximately 8:1 61. d. OxyR-ROS 
Receptors. The OxyR transcription factor regulates the H2O2 oxidative stress response in E. coli. H2O2 alters 
OxyR to activate OxyR DNA binding enabling oxyS RNA transcription. OxyS RNA is a global regulator. OxyR is 
reduced by intracellularly by glutaredoxin-1 (Grx) 30. 
In the GI tract, mammalian cells produce elevated levels of reactive oxygen species 
in response to various wounds and diseases, such as IBD, UC, and CD 24,25. We created a 





native GI bacterium E. coli, as a ‘smart’ device for the eventual autonomous treatment of GI 
diseases based on wound-specific elicitation of ROS in general, and specifically, H2O2.  
OxyR’s sensitivity to H2O2 should allow it to be used as both a monitor of E. coli’s 
response to H2O2 and as a controller of gene expression 29,32,34,62,63. Importantly, initial screens 
suggest that the H2O2 concentrations investigated here are within the reported physiological 
ranges for eventual deployment at wound sites, including those in the GI tract 21. Notably, in 
vivo studies conducted in zebrafish, a popular vertebrate model system, demonstrated a burst 
release of H2O2 (0.1-0.2 mM) to recruit immune cells that serve to prevent infection21. 
Additionally, in vivo mice studies reported H2O2 levels of dermal wounds persisted during the 
immediate inflammatory days (> 200 µM; 2 days post-wounding) as well as post-
inflammatory days (~150 µM; 5 days post-wounding)23. Given these indications, we 
performed studies to evaluate dynamics of the oxyRS promoter system, bacterial cell growth 
upon H2O2 insult, and our desired H2O2-mediated swimming phenotype (Chapter Three). 
2.2 Materials and Methods 
DNA Manipulation and Growth Conditions. The E. coli K-12 W3110-ΔcheZ strain 
(HCW01) was constructed using a one-step inactivation method 64. The genetic constructs 
developed in this study were assembled using standard molecular biology protocols 65. 
Briefly, the oxyR and oxyS gene-promoter sequence from E. coli corresponding to 
NC_010473:4256210-4257127 (+ strand) and NC_010473:42560054256114 (- strand), 




































































The sequences relative to oxyR and oxyS promoter or cheZ were ligated into the single-copy 
vector pFZY1 using T4 Ligase (New England Technologies). Ligations were transformed in 





(50 µg/mL) and incubated at 37°C. Plasmid DNA (Figure 8-a) from each selected clone was 
isolated for sequencing using Qiagen miniprep and analyzed via restriction digestion. The 
same protocol was followed to insert eGFP into pET200 under the T5 promoter (Figure 8-b). 
E. coli K-12 wild type (W3110) and cheZ knockout strains were transformed with pFZY1 
and pFZY1-oxyR-poxyS-cheZ (pHW02) or pFZY1, respectively. 
 












Motility Plates. E. coli W3110-pFZY1 (WT-pFZY1), W3110-ΔcheZ-pFZY1 (HCW01-
pFZY1), and W3110-ΔcheZ-pFZY1-oxyR-poxyS-cheZ (HCW01-pHW02) were grown to 
OD600 ~1.5, diluted to OD600 0.1, and one 2µL droplet of cells (2x105 cells) was added per 
motility plate. In turn, H2O2 (30% ACS-grade, Fisher Scientific, Pittsburgh, PA) was added to 
warm motility agar (Bacto Tryptone broth, BD Biosciences, Franklin Lakes, NJ with 0.5% 
NaCl, Sigma-Aldrich, St. Louis, MO and 0.25% agar, Fisher Scientific, Pittsburgh, PA) and 
poured into Petri dishes (100 mm diameter, 15 mL per plate) to yield concentrations of H2O2 
(0-1 mM). Plates were incubated at 30°C for 18 hours. Negative and positive controls were 
performed in the absence and presence of 100 µM H2O2, respectively, added to the plates. For 
data analysis, technical and biological triplet data were obtained. 
Bacterial Growth. E. coli WT-pFZY1, HCW01-pFZY1 and HCW01-pHW02 were 
inoculated into 25 mL of LB in 125 mL flasks. Bacteria were shaken at 37°C and sampled 
every 30 minutes until OD600 ~0.5. After induction, bacteria were shaken at either 24°C or 
37°C and sampled every 15 minutes for two hours. For data analysis, technical and biological 
triplicate data were obtained. 
H2O2 Consumption. E. coli WT-pFZY1, HCW01-pFZY1 and HCW01-pHW02 were 
inoculated into 10 mL of LB in 50 mL flasks, and shaken at 37°C until OD600 ~0.5. Cells 
were pelleted and resuspended in fresh LB at OD600 0.1 and 0.4. The bacteria were induced 
with 0-200 µM H2O2 in clear 96 well plates (total volume – 200 µL) at 24°C, 250rpm for 5-
15 minutes. All samples were assayed for H2O2 consumption with standards using the 
Quantitative Peroxide Assay Kit (Pierce, Thermo Fisher Scientific, Waltham, MA). For data 





cheZ qPCR. E. coli WT-pFZY1, HCW01-pFZY1 and HCW01-pHW02 were inoculated into 
5 mL of LB in culture test tubes, and shaken at 37°C until OD600 ~0.5. Cells were induced 
with 0.125-1 mM H2O2 at 24°C, 250rpm for 5-15 minutes and pelleted by centrifugation. 
RNA extraction was performed using TRIzol (Fisher Scientific) and samples were treated 
with Dnase I (New England BioLabs) to eliminate possible DNA contamination.  
Quantitative PCR conditions were carried out on an Applied Biosystems 7300 Real-
Time PCR system using a 2-step cycling protocol. Primers were used at a final concentration 
of 400 nM, and 10 ng of RNA was used as template in each 20-l reaction. Each reaction was 
performed in triplicate, with outlying data removed for select samples. 16s rRNA was used as 
the endogenous housekeeping gene. To calculate the levels of cheZ expression ΔCT values 
were calculated by the following equation: ΔCT=CT Target-CT Reference. The ΔΔCT value was 
calculated as ΔΔCT=ΔCT,sample- ΔCT,Wt where each ΔCT are represented by the difference 
between the Target and Reference (16srRNA) values, as above. Also, the relative 
quantification (RQ) is calculated as 2-ΔΔCT. Error bars represent the standard deviation of each 
RQ (2-ΔΔCT+s and 2-ΔΔCT-s). The relative quantification was based on the relative expression of 
cheZ versus 16S rRNA. Wild type E. coli CT values for cheZ were used as reference for all 
samples.  
CheZ Quantification.  E. coli WT-pFZY1, HCW01-pFZY1 and HCW01-pHW02 either with 
or without the pET200-T5-eGFP plasmid were grown overnight, reinoculated into 25 mL of 
LB in 125 mL flasks, and shaken at 37°C until OD600 ~0.5. Cells were induced with 0-300 
µM H2O2 at 24°C, 250rpm for 5, 10, 15, and 60 min and then centrifuged at 4°C, 12,000 rcf 
for 10 minutes. Bacterial pellets were resuspended with 200 µL BugBuster (BugBuster HT, 
EMD Millipore) and protease inhibitor (HALT Protease Inhibitor Cocktail (100x), Fisher 





debris were removed by centrifugation at 4°C, 12,000 rcf for 20 minutes and soluble fractions 
were transferred to new tubes.  
Total protein concentration (Pierce BCA Protein Assay, Fisher Scientific) was 
calculated using the microplate procedure with BugBuster-BSA standards. Pre-stained ladder 
(Benchmark Prestained Protein Ladder, Fisher Scientific), His6-CheZ protein, and 25 µL of 
boiled samples (~110 µg total protein concentration) were loaded into 12% SDS-PAGE gels 
(Bio-Rad). A Semi-Dry Transfer Apparatus (Bio-Rad) was used to transfer proteins to 
nitrocellulose membranes (Thermo Scientific Pierce). The membranes were blocked with 
10% milk (Blotting Grade Blocker Non Fat Dry Milk, Bio-Rad) overnight at 4°C. Membrane 
was washed three times using TBS-T buffer and incubated for 1h 30 min with 1:10,000 anti-
CheZ polyclonal antibody (produced by New England Peptide). Before incubation with anti-
CheZ, it was adsorbed in 25% lysed E. coli cheZ knockout strain extract, 5% Bovine serum 
albumin (BSA), Sigma Aldrich, St. Louis, MO) to decrease nonspecific binding. Membrane 
was washed three times using TBS-T buffer and incubated with 1:15,000 of anti-rabbit 
alkaline phosphatase antibody (Sigma Aldrich) solution 5% BSA, Tris-buffered saline + 
Tween 20 (TBST)). The membranes were developed for 1 hour at 24°C in development 
buffer (with BCIP/NBT), and the reaction was stopped using deionized H2O. 
Statistical Analysis. For most experiments, one-way ANOVA using a multiple comparisons' 
Tukey-Kramer post-test were performed using Matlab (version R2015a). ANCOVA linear 
regression analysis was performed using Prism (Graphpad Prism 7). α values of 0.05, 0.01, 
and 0.001 were used to indicate statistical significance. Data are reported as mean values and 





2.3 Results and Discussion 
2.3.1 Understanding H2O2’s initial effect on bacteria. 
Initial screening studies were carried out to test whether engineered cells exhibited 
enhanced swarming in the presence of H2O2. In addition to evaluating whether a potential 
dose response could be obtained, I was interested to find at what concentration H2O2 would 
prove too toxic so as to permit enhanced motility. In Figure 9-a, control experiments using 
wildtype W3110 cells with empty pFZY1 vector (WT-pFZY1) exposed to 0 or 100 µM H2O2 
demonstrated a base case cell motility exhibited by ~7 cm rings with no obvious adverse 
reaction to the H2O2. Similarly, isogenic cheZ null mutants (HCW01) with empty pFZY1 
vector exhibited no spreading in either case, with 0 or 100 M H2O2. Then, using the same 
null mutants transformed with the oxyRS induced CheZ vector, pZY1-oxyR-poxyS-cheZ, 
(HCW01-pHW02) an increasing ring size was observed with increasing H2O2 from 0 to 300 
µM (2.5-6.5 cm). Interestingly, I found that bacterial spreading decreased dramatically at 500 
µM H2O2, presumably due to peroxide toxicity. Results from biological triplicates are 






Figure 9 - Bacterial swarming on motility agar exposed to varying concentrations of H2O2. a. Motility plates. 
Top Row: WT-pFZY1 and HCW01-pFZY1 controls with 0 and 100 µM H2O2-infused motility plates. Cultures were 
grown overnight. Bottom Row: HCW01-pHW02 with 0-500 µM H2O2-infused motility plates. b. Motility 
Spreading. (left) WT-pFZY1 and HCW01-pFZY1 exposed to 0 or 100 mM H2O2. (right) Quantification of HCW01-
pHW02 with CheZ expression induced by H2O2. Tukey-Kramer ANOVA and multiple comparisons analyses were 
performed with α = 0.05, 0.01 and 0.001. ϯ indicates the samples differed significantly from WT-pFZY1. * 
indicates the samples differed significantly from HCW01-pFZY1. 
In addition, 1 mM H2O2 motility plates resulted in no center colony or spreading 
(data not shown). I note that the 0 µM plate, which had a minimal but non-zero spread, 
suggested that some CheZ activity enabled minimal motility, perhaps due to small levels of 
H2O2 through metabolic activity or simple read-through CheZ transcription and translation 
from our plasmid vector. Interestingly, the 0, 0.5 and 1 mM observations are consistent with 
previously published data 30. Bacterial movement or “swarming” on motility plates does not 
depend on chemotaxis, rather it simply indicates search for nutrients 66–68. In sum, our initial 
screening results are consistent with a hypothesis that H2O2-induced CheZ enables motility 





2.3.2 Characterizing H2O2 uptake and effect on bacterial growth.  
I conducted growth experiments using WT-pFZY1, HCW01-pFZY1, and HCW01-
pHW02 (H2O2-mediated oxyS transcription of CheZ). In addition to CheZ, the motility vector 
confers (i) resistance to bacteria ampicillin (β-lactamase expression), (ii) utilization of lactose 
(lacZ, lacY, lacA, expression), and (iii) copy number maintenance by expression of repE 
(mini-F plasmid). In Figure 10 and Figure 11, I grew cells at 37°C until 120 min when I 
added H2O2. At induction, the cultures were split to grow at 24°C and 37oC to examine how 
the temperature and H2O2 concentrations affect bacterial growth and H2O2 consumption. 
Regression analysis indicated that all preinduction growth rates were similar (data not 
shown). Then, analogously, after a short transient phase, cultures continuing after OD600 
~0.45 all grew at similar rates irrespective H2O2 for each temperature level (Figure 10-b, c 
(24oC), Figure 11-a, b (37oC)) until H2O2 concentrations above 500 µM. 
 
 
Figure 10.  Effects of H2O2 on cell growth at 24°C. a. Cell growth curves. WT-pFZY1 and HCW01-pFZY1 and 
HCW01-pHW02 vector at different levels of H2O2. b. Cell growth curves following H2O2 addition. HCW01-
pHW02 growth with 0-1000 µM H2O2 induction concentrations. Lines indicated are least squares regressed best 







Figure 11. - Effects of H2O2 on cell growth at 37°C. a. Post-induction growth curves. WT-pFZY1 and HCW01-
pFZY1 with and without 100 µM H2O2 were controls. b. Tabulated specific growth rates. HCW01-pHW02 growth 
with 0-1000 µM H2O2 induction concentrations. All linear regression analyses for HCW01-pHW02 were 
compared to 0 µM H2O2. 
I noted that swarming experiments indicated reduced motility at concentrations above 300 
µM, perhaps suggesting that swarming was more sensitive than cell growth to H2O2 at 
elevated peroxide levels. However, swarming and growth experiments are quite different, 
particularly in that exposure to H2O2 occurs under different time scales. Notably, the growth 
curves represented a single exposure to H2O2 at the start of induction. However, the bacteria 
in the motility plates were constantly and consistently exposed to the same concentration of 
H2O2 as they swarmed outwards. Therefore, the continuous exposure to H2O2 in the motility 
plates experiments also represented the bacteria’s ability to consume H2O2 below or above 
the toxicity threshold and subsequent response (in addition to stimulating swimming). 
2.3.3 H2O2-mediated cheZ transcription.  
I conducted studies using qPCR to quantify cheZ expression. Data were normalized 
to 0 µM H2O2. For 15 minute H2O2 induction (meaning samples taken 15 min after 
introduction of H2O2 at various levels), qPCR data exhibited similar trends to our previous 
motility plate studies – a rise in gene expression from 0 to 300 µM and a decrease at 500 µM. 





finding maximal cheZ mRNA levels at 400 µM 15 min post induction. Statistical analyses 
were performed by lumping tests above 100 µM and demonstrating significance relative to 
each of the lower levels (multiple comparisons one-way ANOVA, Tukey-Kramer post-test). 
Importantly, cheZ mRNA increased monotonically with H2O2 over time for all ranges tested 
Figure 12-a). A more detailed analysis using only 5 &10 min. induction with 12.5-200 µM 
H2O2 showed similar increasing trends (Figure 12-b). Interestingly, only 12.5 M was 
needed to stimulate cheZ expression and this was observed at the first non-zero time point (5 
min). 
 
Figure 12.  CheZ qPCR. a. 15 minute qPCR analysis. b. 5-10 minutes qPCR analysis. WT-pFZY1 is used as a 
control (i.e., genomic cheZ expression). All cheZ levels for HCW01-pHW02 were normalized to 0 µM H2O2 
wildtype cells. Tukey-Kramer ANOVA and multiple comparisons analyses were performed with α = 0.01 and 
0.001. 
2.3.4 H2O2-mediated CheZ protein production.  
In Figure 13-a, b, I used Western blotting to correlate H2O2 with CheZ protein levels 
in the HCW01-pHW02 cells. At 15 min, CheZ levels increased with H2O2. I found peak 
levels at 50-100 µM; this tended to decrease at the higher H2O2 levels (although this was not 
a statistically validated trend) (Figure 13-a). Interestingly, the CheZ from uninduced 
wildtype cells was not revealed, presumably below detection in these blots. Moreover, I 
found no CheZ bands in the uninduced HCW01-pHW02 cells. Subsequent studies were 






Figure 13. - CheZ Western blot analyses. CheZ is expressed without a purification tag; Westerns are performed 
using rabbit anti-CheZ antibody (see Methods). a. H2O2 induction for 15 and 60 minutes. b. H2O2 induction for 5 
and 10 minutes. His6-CheZ and WT-pFZY1 were controls. 
Results were consistent and reveal that at 12.5 µM and 5 min H2O2 induction, there was 
significant CheZ present (significantly more than the wildtype cells). This level increased in 
time and in peroxide concentration until 100 µM above which perhaps H2O2 toxicity prevented 
further increases. These findings directly corroborated the relatively fast mRNA responses.  
2.3.5 Quantifying H2O2 consumption and characterizing CheZ expression in the 
presence of a second constitutive plasmid 
Initially, I examined the effects of one plasmid (pHW02) versus two plasmids 
pHW02, pET200-t5-eGFP) on cheZ genotype. Previous qPCR experiments using pHW02 
and varying concentrations of H2O2 had shown that within 5-10 minutes, the bacteria turn on 
cheZ mRNA expression had shown increasing mRNA expression corresponding to increasing 
H2O2 concentrations (12.5-200 µM; data not shown). After 15 minutes of induction for 
HCW01-pHW02, I clearly can see a statistically significant increase of cheZ mRNA 
expression in the single plasmid system when induced with 50-100 µM H2O2 (α = 0.005, 





levels after 15 versus 60 minutes of H2O2 induction, I observed a significant qualitative 
difference between 1 plasmid versus 2 plasmids. I start to see faint CheZ bands for the 2 
plasmid system after 60 minute induction; more discernable bands are visible with the 1 
plasmid system after 15 and 60 minute inductions (Figure 14-b). This suggests that addition 
of the second plasmid with the constitutive fluorescence protein attenuates cheZ transcription 







Figure 14 - H2O2-induced CheZ production. a. 1 plasmid – 15 minute qPCR analysis. b. 1 plasmid vs. 2 plasmid 
CheZ Western Blot. H2O2 induction for 15 and 60 minutes. His6-CheZ and WT-pFZY1 were controls. c-d. H2O2 
consumption absorbance curves. WT-pFZY1 and HCW01-pFZY1 (controls) and HCW01-pHW02 induced with 0-
200 µM H2O2 for 5-15 minutes at OD 0.1 and 0.4 with absorbance measured at 595 nm. b. Calculated 
unconsumed H2O2. Tukey-Kramer ANOVA and multiple comparisons analyses were performed with * α = 0.005. 
* indicates the samples differed significantly from all samples. 
Previous studies have examined the effects of plasmid-encoded gene overexpression 
on quorum sensing and metabolic burden 38, but it is unclear how this overexpression affects 





OD 0.4, all of the H2O2 (50, 100 µM) was consumed within 5 minutes (Figure 14-c, d). In 
order to quantify how the second constitutive plasmid affects H2O2 consumption rate, bacteria 
were induced at OD 0.1; after a 5 minute induction with 100 µM H2O2, there is a statistically 
significant amount of H2O2 left in the 1 and 2 plasmid systems (α = 0.001, 0.005, 
respectively), and the 2 plasmid system still has significant H2O2 unconsumed after 10-15 
minutes (Figure 14-c, d).  
Additionally, I observed different growth and induction rate differences between the 
one and two plasmid systems (Figure 15-a). Linear regression analysis confirmed there is a 
statistically significant difference at each H2O2 concentration when comparing between the 
one and two plasmid systems (Figure 15-b, c). Based on these results, I can definitively state 
that the second constitutive GFP plasmid burdens metabolic growth; additionally, the 
induction and expression of CheZ does not affect the metabolic growth. With these results, I 
can predict and quantify the motility and metabolic burdens when adding and modifying 






Figure 15 - Standard growth curves. a. Control and experimental standard growth curves. WT-pFZY1 and 
HCW01-pFZY1 with and without pET200-t5-eGFP were controls (left). HCW01-pHW02 ± pET200-t5-eGFP with 
0-100 µM H2O2 induction concentrations (right). The black arrow indicates the induction OD and time. b. Prism 
linear regression ANCOVA analyses. Linear regression analyses were conducted with samples at induction time.  
All linear regression analyses compared the two plasmid system to the one plasmid system. 
2.4 Conclusion 
We constructed a simple synthetic H2O2-responsive promoter system. 
Complementary studies31,36,69 demonstrate that additional regulatory constructs based on 
engineered plasmid controllers and/or engineered host cells enable tight or “tuned” control of 
gene expression based on signal molecule concentration. We note, however, that significant 
modification of host genotype can alter cell physiology so as to potentially hinder native 
phenotypes that are required for optimal cell function 70. That is, the current system restores 





We employed population based analytical methods to characterize the system that 
enable E. coli to sense H2O2 in highly-controlled and defined manners. Studies of CheZ 
expression revealed a practical threshold level of ~12.5 µM was suitable for rapid and 
sustained induction of CheZ. We noted also that the bacteria were able to quickly consume or 
otherwise dissipate H2O2, diminishing its effects so that over a putative therapeutic range, 
bacteria exhibited little to no growth inhibition. Thus, we suggest that the synthetic biology 
framework in this work could be applied for the detailed design of engineered probiotics that 






Chapter 3: Engineer Bacteria to Swim In Response to and 
Towards a H2O2-Rich Environment. 
 
3.1 Introduction 
In this chapter, I turn to the endogenous, wound-indicating signal molecule, H2O2, as 
a directional cue; I fully recognize the potential conflict in that induced directionality of 
therapeutic strains could, in turn, lead to their own damage. In order to attract our engineered 
bacteria toward to a localized injury marked by the presence of H2O2, I developed a system 
that guides E. coli swimming towards H2O2 by controlling the (i) ratio of run to tumble, and 
(ii) cell velocity in the presence of an H2O2 gradient. Bacterial motility regulator, CheZ, is a 
phosphatase responsible for controlling the level of phosphorylated CheY, which, in turn, 
regulates the tumbling mode of bacterial swimming 30,34 (Figure 7). For this, cheZ was 
expressed under control of the oxyRS gene-promoter system induced by the presence of H2O2 
in cheZ- oxyRS+ mutants; I retained the native oxyRS genes to prevent additional oxidative 
stress to the bacteria and deleted genomic cheZ to examine how exogenous H2O2 affects 
motility.  
The CheY and CheZ phosphorylation and dephosphorylation cascade (in conjunction 
with methylation and demethylation cascades) activates the bacterium’s tumbling and 
running motions 30,34, respectively (Figure 7). As noted above, elevated H2O2 activates OxyR 
30 which then induces OxyS RNA transcription. H2O2 concentrations in the 102 – 103 µM 
range causes toxicity to E. coli and decreases E. coli survival 71. In physiologically relevant 
mice studies, researchers showed that a range between 0.1 to 0.3 mM of H2O2 was generated 
at the site of the ROS burst 15,17,72. Hence, given the potentially 10-fold difference between the 
physiologically relevant and toxic levels, I hypothesized that engineered bacteria might 





significant oxidative stress. Thus, such engineered H2O2-controlled bacteria may allow for a 
wide range of application for future therapies or applications. 
Additionally, in bacterial motility experiments and publications, researchers engineer 
the bacteria to contain a constitutively-fluorescent protein; this allows researchers to track the 
bacteria and quantify motility or other parameters with reduced background noise and fewer 
artifacts compared to phase-contrast tracking. Another focus of this research centers on how 
constitutively-expressed protein affects engineered motility. 
3.2 Materials and Methods 
Growth Conditions. Bacteria were grown in LB media supplemented with ampicillin (50 
µg/mL) and incubated at 37°C in a shaker at 250 rpm for all growth experiments. For all 
overnight inoculations, bacteria were grown from glycerol frozen stock; all morning re-
inoculations were adjusted with sterile media to OD600 0.05. Except for motility plates, 
transwell assays and microfluidic assays, H2O2 induced experiments were conducted at 24°C 






Motility Videos. E. coli WT-pFZY1, HCW01-pFZY1 and HCW01-pHW02 (with pET200-
T5-eGFP for two plasmid experiments) were inoculated into 5 mL of LB in 25 mL flasks, and 
shaken at 37°C until OD600 ~0.5. Bacteria were split into 1 mL cultures in culture test tubes 
and induced with 0 µM H2O2 (control) and 12.5-100 µM H2O2 at 24°C, 250 rpm for 5-15 
minutes. The bacteria were centrifuged at 1,000 rpm and 4°C, washed twice, and resuspended 
in DPBS for brightfield and fluorescence motility videos (CellSense). Videos were recorded 
for 100 frames for subsequent Tumble Score 73 Matlab (version R2015a) analysis. Phase 
contrast (brightfield) movies were captured using 50 ms white light exposure without binning 
(1360x1024 pixel size, 319.48 nm/pixel). For data analysis, technical duplicate and biological 
triplicate data were obtained. 
Transwell Motility Assays. E. coli WT-pFZY1, HCW01-pFZY1 and HCW01-pHW02 were 
grown overnight, reinoculated into 5 mL of LB in 25 mL flasks, and shaken at 37°C until 
OD600 ~0.5. Cells were washed twice and resuspended in DPBS buffer to OD600 ~0.15. In a 6 
well plate (Corning), 2.5 mL of cell suspension was added. In the top transwell, 1.5 mL of 
DPBS ± 0-300 µM glucose or 0-300 µM H2O2. Transwells were incubated at 37°C for two 
hours for the DPBS buffer and 25-300 µM glucose transwells; based on the H2O2 diffusivity 
properties dependent on temperature74 and a Transwell Comsol model75, the H2O2 transwells 
were incubated at 37°C for 45 minutes to ensure that the H2O2 gradient across the transwell 
membrane persisted throughout the experimental time course. For data analysis, technical 
duplicate and biological triplicate data were obtained. 
Static Gradient Device. E. coli WT-pFZY1, HCW01-pFZY1 and HCW01-pHW02 were 
inoculated into 5 mL of LB in 25 mL flasks, and shaken at 37°C until OD600 ~0.5. Cells were 





bottom channel of the motility device (Figure 22-a)76 was pretreated with Pluronic F-127 
(Sigma-Aldrich, St. Louis, MO) for 1 hour to minimize nonspecific retention of cells to 
channel walls. Before cell introduction, DPBS buffer was pumped into both source and sink 
channels using 1 mL syringe and syringe pump at a rate of 120 μL hr-1. Bacteria were grown 
until OD600 ~0.6-0.8 and then introduced into the bottom channel at the cell inlet. This 
initially loads bacteria for subsequent filming and study. Both ends of the bottom channel 
were then wiped and taped to stop flow. They are then exposed to a gradient introduced by 
providing fluids in the upper source and sink channels, each having different concentrations 
of the gradient solute. For traditional chemotaxis experiments, a glucose solution (1 mM in 
DPBS) was then introduced at a rate of 50 μl hr-1 to replace DPBS in the source channel and 
to establish a maximum gradient concentration of 100 µM. The sink channel was maintained 
with 1 mM DPBS. This methodology rapidly generates a glucose gradient within the bottom 
channel. Note that there is no flow experienced by the cells in the lower channel (for details, 
see Shang et al., 2017). The time when glucose was added to the source channel was set to be 
t = 0. Bright-field images and videos were taken in the middle of the bottom channel at 0, 10, 
20 and 30 minutes by a 20X Olympus objective. Then, for pseudotaxis experiments, H2O2 
solutions (0.5 or 3 mM; diluted in DPBS) were introduced using the same method as the 
glucose solution, with final maximum H2O2 concentration gradients of 50 and 300 µM. 
Bright-field images were taken at 0, 5, 10, 12, 16, 18, and 20 minutes by a 20X Olympus 
objective.  
Statistical Analysis. For most experiments, one-way ANOVA using a multiple comparisons' 
Tukey-Kramer post-test were performed using Matlab (version R2015a). α values of 0.05, 
0.01, and 0.001 were used to indicate statistical significance. Data are reported as mean 





3.3 Results and Discussion 
3.3.1 Previous phenotypic characterization in response to H2O2 
Previously in Chapter 2, I initially characterized HCW01-pHW02’s response to 
H2O2 by using motility plates (Figure 9) infused with varying concentrations of H2O2; this 
allowed me to determine an optimal testing range of 0-200 µM H2O2 induction, which is also 
extensively covered and confirmed in literature as the physiological in vivo range for various 
animal models21,23. Additionally, standard growth curves showed that, with only pHW02, 
inducing with varying H2O2 concentrations had no statistically significant effect on growth 
(Figure 10); however, adding a second plasmid with constitutively expressed protein added 
metabolic burden and statistically significantly burdened bacterial growth after H2O2 
induction (Figure 15). 
3.3.2 H2O2-mediated motility for pHW02 
In order to analyze bacterial movements and to differentiate chemotaxis, pseudotaxis, 
and importantly, swimming from swarming (Figure 9), I carried out experiments in 2D using 
microscopy and cell motility videos. To simplify cell trajectory tracking, I transformed cells 
with a second plasmid constitutively expressing eGFP. In this way, non-motile cells could be 
differentiated from dust particles and debris. In Figure 16-a, a few eGFP trajectories are 
depicted from representative traces. That is, a white trace line is produced as a cell moves 
from the beginning of its trajectory to its end. Similarities between the mutant and engineered 
cells without H2O2 were striking, as were the wildtype cells without H2O2 and engineered 
cells with 100 µM H2O2.  
In Figure 16-b, for cells without the GFP plasmid, Rose plots are depicted wherein 
many traces are superimposed with the initial points set at the origin of the coordinate axes. 
First, trajectories were observed in every direction as expected, illustrating random 





behaved as expected; E. coli WT-pFZY1 exhibited smooth running trajectories with random, 
interspersed tumbling while the E. coli HCW01-pFZY1 displayed increased tumbling with a 
few random spurts of running. Notably, the HCW01-pFZY1 cells moved far less from the 
origin than the WT-pFZY1 cells owing to the cheZ deletion and subsequent paucity of runs. 
Similarly, uninduced (0 µM H2O2) HCW01-pHW02 exhibited a phenotypic profile similar to 
HCW01-pFZY1. When induced with 100 µM H2O2, HCW01-pHW02 (Figure 16-a, b) 
showed a phenotype more similar to WT-pFZY1, indicating that motility and CheZ running 







Figure 16 - Characterization of H2O2-induced motility. a. Fluorescent trajectory images. 5 second trajectories of 
fluorescent WT-pFZY1, HCW01-pFZY1, and HCW01-pHW02 (0 and 100 µM H2O2) were mapped. b. Rose graphs 
of trajectories. 5 second trajectories are displayed from each trajectory’s origin to visualize the path lengths and 
angle changes. c. Average velocities. The average velocities of the control bacteria (WT-pFZY1, HCW01-pFZY1) 
versus the engineered bacteria (HCW01-pHW02; 0-200 µM H2O2). d. Percentage of time within trajectories of 
running vs. tumbling based on angle change. Trajectories were calculated based on 5 second trajectories for all 
bacteria. ‘Running’ trajectories (solid bars) were based on the time it took the bacteria to move < 1 radian/s; 
‘tumbling’ trajectories (lined bars) were based on the time it took the bacteria to move > 1 radian/s. e. Ratio of 
path length: Euclidean distance. The total distance traveled (path length) versus displacement (Euclidean 
distance) were calculated based on the initial and final points of 5 second trajectories for all bacteria. Data are 
presented as box and whisker plots with mean and quartiles indicated in box and extremums as whiskers. All data 
are quantified for 5 second trajectories. Tukey-Kramer ANOVA and multiple comparisons analyses were 
performed with α = 0.05. * indicates the samples differed significantly from WT-pFZY1. ϯ indicates the samples 
differed significantly from HCW01-pFZY1. 
To more directly compare the phenotypic responses, motility movies were again 
taken also without GFP-yielding plasmids (I had suspected increased burden due to the GFP 
expression). I used 5-sec trajectories and similar computational analyses, except that all 
stationary particles were discounted instead of just non-fluorescing particles. Quantified 
videos thus represent only moving cells. For statistical analysis, mean velocities were 
analyzed. I found HCW01-pHW02 induced with 50-200 µM H2O2 (5, 15 min. induction) had 





bars represent 5 & 15 min samples). Also, CheZ induction with 75-200 µM H2O2 for both 5 
and 15 minutes showed significant (α = 0.05) increases compared to the WT-pFZY1 cells 
with velocities reaching ~23 µm/s and 19 µm/s, respectively. HCW01-pHW02 with 0 µM 
H2O2 were observed to have similar velocities to the HCW01-pFZY1 cells (~16.5 µm/s, 
Figure 16-c). Velocities were observed to increase monotonically from 12.5 M to 75 M 
H2O2. 
Another quantity used to characterize swimming is the net angle change as a cell 
moves from frame to frame. For 5 second trajectories, the percentage of trajectories that 
exhibited a net angle change of < 1 radian/s and > 1 radian/s 61 were measured; this is 
calculated by resolving the direction and angle change between subsequent frames and 
averaging over the 5 second trajectory to classify the bacteria as “running” or “tumbling”, 
respectively. Swimming percentages, which I denote the fraction of time running versus 
tumbling, were calculated to be ~20-25% for the HCW01-pFZY1 cells and the uninduced 
HCW01-pHW02. The percent swimming observed for the HCW01-pHW02 induced with 
12.5 to 25 µM H2O2 were notably higher (~35%). At concentrations above 50 µM H2O2, cells 
were observed to have increased running (~40-48%, solid bars, Figure 16-d). Conversely, the 
increase in percent running per trajectory was inversely proportional to the average angle 
change per trajectory (Figure 17-a). The increased velocity observed with H2O2 is consistent 
with the increased fraction of running within a trajectory. In Figure 17-b, I demonstrate that 






Figure 17 - Phenotypic expression of H2O2-induced motility. a. Average angle change. The average angle 
change in degrees per 5 second trajectory of the control bacteria (WT-pFZY1, HCW01-pFZY1) versus the 
engineered bacteria (HCW01-pHW02; 0-200 µM H2O2). These values are inversely proportional to the percent 
running per trajectory. b. Mean vs. median velocity. Quantification and comparison of reported mean vs. median 
velocities for all bacteria. Slightly lower velocity and higher variability are associated with the median velocity. 
Median and mean velocities follow similar trends. ϯ (α = 0.05) indicates the samples differed significantly from 
HCW01-pFZY1. 
Interestingly, I observed that CheZ protein expression increased nearly 
monotonically with H2O2 concentrations until ~100 M, which mirrored the calculated 
swimming velocity and percentage of run versus tumble. At H2O2 levels above ~100 M, the 
CheZ level appeared to drop and the swimming parameters appeared to plateau. Also, the 
levels reached appeared to match the WT phenotype. This was contra-indicated by the cheZ 
mRNA levels which increased monotonically to ~ 400 M, suggesting other cellular control 
mechanisms override continued increases in cheZ mRNA.  
I did note, however, that the lower concentrations of H2O2 yielded higher variability 
in cheZ phenotypic expression within the population. For example, I found greater ranges in 
the standard deviations (25 and 75% quartiles) and extremums in the ratio of path length to 
Euclidean distance at the lower levels (Figure 16-e). This measure is the ratio of the sum of all 
discrete distances travelled and the net distance from the beginning to end of a trajectory. It 
had significant variability and thus was an interesting measure to characterize the population 
distribution and its evolution with H2O2. In general, with increasing H2O2 concentration and 





towards the observed wildtype values. Similar phenotypic focusing phenomena were 
observed in response to addition of quorum sensing signaling molecules 36.  
3.3.3 Plasmid-encoded protein attenuates bacterial motility 
In order to analyze bacterial movements and to differentiate and quantify the burden 
of the second constitutive protein, I carried out experiments in 2D using phase contrast 
microscopy and cell motility videos. I used 5s trajectories and computational analyses with 
all stationary particles discounted. Using this approach, I were able to determine velocity and 
direction of engineered and wildtype strains. In Figure 18-a, a few trajectories are depicted 
from representative traces; that is, a black trace line is produced as a cell moves from the 
beginning of its trajectory to its end at the end of a video trace. Similarities between the 
mutant and engineered cells without H2O2 are striking, as are the wildtype cells without H2O2 
and engineered cells with H2O2. I do not discern any differences between the one and two 
plasmid trajectories. In Figure 18-b, Rose plots are depicted wherein many traces are 
superimposed with the initial points set at origin of the coordinate axes. First, I observed 
increasing distances with increasing H2O2 concentrations with both systems. Second, the 
trajectories are observed in every direction as expected; however, when comparing the one 
and two plasmid graphs, the two plasmid system appears to have shorter path lengths 







Figure 18 - Phenotypic expression of H2O2-induced motility. a. Phase contrast trajectory images. 5 second 
trajectories of WT-pFZY1, HCW01-pFZY1, and HCW01-pHW02 (0-100 µM H2O2) ± pET200-eGFP were 
mapped. b. Rose graphs of trajectories. 5 second trajectories are displayed from each trajectory’s origin to 
visualize the path lengths and angle changes with and without the pET200-eGFP plasmid. 
To more directly quantify the phenotypic responses to H2O2 with and without 
constitutive fluorescence, I performed computational analyses 73 of the motility videos. Per 
trajectory, increases in speed were observed in both the one and two plasmid systems. With 
H2O2 addition, I were able to recover native velocities without a change in growth rate 
(Figure 19-a, b); however, the addition of the constitutive fluorescent protein consistently 
and significantly slowed down tumbling and running in both the controls and H2O2 induced 
bacteria compared to the one plasmid system. This speed reduction links the effects of 
metabolic burden previously observed 36 with the direct effect on motility burden.  
I note, however, that despite the statistically significant differences in speed, there is 
no significant difference of percent running (Figure 19-c, d) between the H2O2 induced one 
and two plasmid systems. For 5 second trajectories, the percentage of trajectories that 
exhibited a net angle change of < 1 radian/s and > 1 radian/s were classified as “running” or 
“tumbling”, respectively 61. WT-pFZY1 and H2O2-induced HCW01-pHW02 running times 
were calculated to be ~40-50%; the H2O2-induced bacteria recovered to native run versus 





were significantly reduced at ~20-25% (solid bars, Figure 19-c, d). Finally, when comparing 
the ratio of path length to Euclidean distance (Figure 19-e, f, g), the bacteria without cheZ in 
both systems exhibited a more uniform distribution between the median and quartiles 1 and 3 
with large whiskers (highest and lowest reported values), indicating a dominance of tumbling. 
Whereas, with WT-pFZY1 cells, one observes more variation between the median and 
quartiles 1 and 3 with smaller whiskers in the one plasmid compared to the two plasmid 
system. With increasing H2O2 concentrations and induction time, the quartile and variability 
(box and whiskers) shrink in size; similar to the controls, the two plasmid system shows less 
variability between the median and quartiles (Figure 19-g) compared to the one plasmid 
system. Based on the velocity and % running data, I theorize that the constitutive protein 







Figure 19 - Phenotypic expression of H2O2-induced motility – 1 vs. 2 plasmid. a-b. Average velocities. The 
average velocities of the control bacteria (WT-pFZY1, HCW01-pFZY1) versus the engineered bacteria (HCW01-
pHW02; 0-200 µM H2O2) without (left) and with pET200-eGFP (right). c-d. Percentage of trajectories running vs. 
tumbling based on angle change percentage. The percentage of trajectories (based on the initial 5 second 
trajectories of all bacteria) that were ‘running” (solid bars) versus “tumbling” (lined bars) based on the time it 
took to move either < 1 radian/s or > 1 radian/s, respectively. e-g. Ratio of path length: Euclidean distance. The 
total distance traveled (path length, blue line) versus displacement (Euclidean distance, red line) were calculated 
based on the initial 5 second trajectories of all bacteria and plotted as box and whisker.  All data is quantified for 
5 second trajectories. All left columns are the one plasmid system. All right columns are the two plasmid system. 
Tukey-Kramer ANOVA and multiple comparisons analyses were performed with α = 0.05-0.001. * indicates the 
samples differed significantly from the one plasmid system. ϯ indicates the samples differed significantly from the 






3.3.4 pHW02 – Chemotaxis and Pseudotaxis  
Transwell apparatus 
Transwell motility assays allow for direct observation of free swimming in 3D, and 
more specifically, initial analysis of chemotaxic versus pseudotaxic responses. I used Comsol 
to provide predicted H2O2 concentration gradients over time at 37°C for different initial H2O2 
levels. At time zero, H2O2 was assumed to be uniform within the upper chamber, which in 
turn was assumed quiescent (no flow). In Figure 20, I have indicated the predicted 
concentrations at points A-D over time, without incorporating H2O2 consumption by the 
bacteria. By examining concentrations at various locations relative to each other (e.g., 
difference between A&B, or C&D), our simulations suggest that the H2O2 gradients persisted 
over the course of the subsequent swimming experiments (Figure 20-b).  
 
Figure 20 - Simulated H2O2 levels (Comsol). a. Comsol model heat maps. Four points (A-D) were recorded to 
estimate various H2O2 concentration gradients over time. Heat gradient maps were constructed for 45 minute 
(left) and 90 minute (right) gradients. Heat maps were generated using 50, 100, and 200 µM H2O2 starting 
concentrations. b. H2O2 gradient curves over time. For each point (A-B, left; C-D, right), the H2O2 gradients were 





I suspended exponentially growing bacteria in the bottom of a transwell apparatus 
(Figure 21-a) containing Dulbecco's phosphate-buffered saline (DPBS) and at time zero, 
introduced either H2O2 or glucose in order to evaluate the swimming of bacteria vertically 
upward into the upper chamber. Glucose represents a chemotaxis positive control. By 
analyzing starting conditions with bacteria only present in the lower chamber and ending 
conditions with swimming bacteria in the upper chamber, I evaluated the extent to which 
bacteria swim to a chemoattractant such as glucose. These studies are analogous to our 
previous work 75 wherein bacteria were found to swim towards quorum sensing autoinducer 
AI-2, another known chemoattractant. In pseudotaxis, if the run of a tumble/run scheme is 
more frequent and/or of longer duration in the presence of a molecular stimulant, then on 
average the bacteria will accumulate in the direction of the stimulant 77,78. In our tests, 
statistical analysis (multiple comparisons one-way ANOVA, Tukey-Kramer post-test) shows 
significant differences from WT-pFZY1 with DPBS (control) in the upper chamber compared 
with WT-pFZY1 with glucose (chemoattractant) in the upper chamber (Figure 21-b). 
Additionally, I found that HCW01-pHW02 induced with H2O2 migrated to the upper chamber 







Figure 21 - Chemotaxis versus pseudotaxis bacterial response. a. Transwell scheme and simulated transwell 
gradient. Bacteria were suspended in DPBS in the bottom of the transwell apparatus. DPBS, DPBS + 100 µM 
glucose or DPBS + 100 µM H2O2 solutions were loaded into the top of the transwell apparatus for testing. DPBS 
in both top and bottom served as random motility controls. Chemotaxis (towards glucose), or pseudotaxis 
(towards H2O2), respectively, were also determined. b-c. Quantification of bacterial motility. For chemotaxis, the 
bacteria cell number was assayed in the upper chamber after 2 hours; for pseudotaxis, the bacteria cell number 
was assayed in the upper chamber after 45 minutes. Tukey-Kramer ANOVA and multiple comparisons analyses 
were performed with α = 0.05, 0.01 and 0.001. Blue * indicates the samples differed significantly from HCW01-
pFZY1 + DPBS. ** HCW01-pHW02 + DPBS. 
Importantly, while the pseudotaxic response to H2O2 was notably lower than the chemotaxic 
response to glucose, the result that cells swam to the upper chamber was statistically relevant 
(e.g., different than random swimming). This is particularly noteworthy in that previous 
findings have shown that bacteria swim away from H2O2 79; however, our findings suggest 
that rather than swim away from the potentially toxic ROS molecule, the bacteria instead 
swam towards H2O2. When considering our results from Figure 10 and Figure 14, I suspect 
that these cells metabolize or dissimilate the potential toxin at the same times they were found 
to swim towards it. To our knowledge, this is the first such report, and this suggests that 
pseudotaxis can be controlled by internally regulating the CheZ level via externally applied 
H2O2. 
Microfluidic device 
While transwells provided a quantitative method for determining globally the 
directional responses to glucose and H2O2, I performed additional studies using a microfluidic 





gradients. That is, using a well-controlled microfluidic device that employes a well-controlled 
and more uniform concentration gradient enables one to anaylze the bacteria’s phenotypic 
response both visually and analytically on a per cell basis so that cell and system design 
parameters for future applications can be estimated more accurately. As noted in Methods, 
bacteria were introduced into the bottom channel of a dual chamber device at the cell inlet 
(Figure 22-a, top view). These cells are localized generally at the inlet but are free to 
disperse within the bottom channel (Figure 22-a, cross-section). As soon as cells are added, 
the ends are taped to stop flow. Immediately thereafter, DPBS buffer is introduced into the 
sink channel of the top layer and either glucose or H2O2–supplemented DPBS solution was 
added to the source channel (Figure 22-a) which started the experiment (t = 0). The 
concentration gradient of solute (glucose or H2O2) is established in the area indicated by the 
y-axis arrow (Figure 22-a, top or cross section views). The cells in this lower channel are 
then free to swim according to the emerging gradient. A full description of the device and 
established gradients is available76. At appropriate time intervals, images near the sink, 
middle, and source were taken to represent the prevailing population and cell density. In 
Figure 22-b, I quantified the WT-pFZY1 chemotaxic response to glucose. Based on data 
normalized to the cell numbers at time 0 and at the source, I observed a slight increase over 
time in the source population for WT-pFZY1 with DPBS (no attractant). As I presume there 
may have been more cells at the source end of the device (closest to the inlet), this represents 
the natural spreading of the population to unpopulated regions. Then, when the cells were 
exposed to a glucose gradient, I observed a far greater increase in population at the source. 
This increase was observed to be sustained for over 20 min. Analogously, in Figure 22-c, I 





increasing amounts of H2O2, I observed an increase in the number of bacteria found at the 
source (Figure 22- c).  
 
Figure 22 - Pseudotaxis using a gradient-generating microfluidic device. a. Microfluidic device scheme76. Cells 
are introduced to the cell inlet (Top view) which places cells in the bottom channel (Cross-section). The chemical 
gradient is established by introducing buffer and attractant in flow at sink and source locations, respectively (see 
Methods). Cells are imaged near source, sink, and in the middle of the gradient (Top view). b-c. Chemotaxis vs. 
pesudotaxis population source image analysis. Images were taken at the indicated time intervals with t=0 
designated to be the introduction of glucose or H2O2 solution into the source channel. All population counts 
normalized to time 0 population counts at the respective positions. WT-pFZY1 with 100 µM glucose as the source 
yielded a chemotaxic response (towards glucose source). HCW01-pHW02 with H2O2 demonstrated pseudotaxis. 
Moreover, I found that in only 5 minutes exposure to a 300 mM H2O2 gradient, a notable 
increase in bacteria was found. Consistent with our previous results, the cells exposed to 
lower H2O2 concentrations (50 µM) responded more slowly and to a lesser extent. These 
results again demonstrate that CheZ-engineered bacterial cells can be “programmed” to swim 
towards H2O2. I presume that as cells moved towards the H2O2, they also helped to dissipate 
the level, enabling additional cells behind to swim towards the increasing peroxide level. I 






In summary, we engineered a synthetic H2O2-responsive promoter system and 
quantified the additional motile burden caused by constitutive GFP expression. We 
constructed a simple synthetic H2O2-responsive promoter system and used the system to 
guide bacterial swimming. We employed population based and single cell based analytical 
methods to characterize the system that enable E. coli to sense and pseudotax towards H2O2 in 
highly-controlled and defined manners. Studies of CheZ expression and motility revealed a 
practical threshold level of 50-200 µM was suitable for rapid and sustained induction of CheZ 
and cell swimming. Importantly, we identified and quantified how the constitutive GFP 
expression, a method commonly used by researchers conducting motility experiments 80,81, 
significantly slows down bacteria without affecting the cheZ network. It is commonly known 
and characterized that flagella require ATP and ATPases to export protein and rotate flagella 
82,83; this indicated that the two plasmid bacteria experience an energetic metabolic burden, 
thus reducing the bacterial growth rate and velocity. Despite the burden of GFP, the 
engineered bacteria quickly consumed the H2O2 and turned on bacterial running. 
In physiologically relevant settings (e.g., GI tract), reported H2O2 concentrations in 
mice studies were > 200 µM during the inflammatory phase and ~150 µM during the post-
inflammatory phase in dermal wounds 84; additional mice studies have shown that a range of 
100-300 µM of H2O2 was generated at the site of the ROS burst release 15,17,72. 
Correspondingly, our studies have indicated engineered cells functioned satisfactorily when 
exposed to H2O2 levels up to the 100-300 µM range, experiencing diminished CheZ 
expression, growth and motility at much higher levels (~500 µM). Thus, we suggest that the 





detailed design of engineered probiotics that would be deployed for directed treatment in the 






Chapter 4: Optimize Protein G Surface Display and Express 




4.1.1 Protein G Surface Display 
In nature, cell surfaces use membrane-bound proteins to bind antibodies at their 
constant fragment (Fc) region. These protein-bound antibodies are secured to supramolecular 
structures, such as the cell membrane85. The human body and other organisms developed and 
evolved antibodies with a plethora of different antigen-binding fragment (Fab) variations. 
These variations allow the antibody to bind the Fab region to a specifically-recognized 
antigen; numerous antigens are upregulated by the immune system in response to injury, 
infection, and/or disease. These upregulated antigens serve as excellent targets for innovative 
bacteriotherapeutics86. By utilizing both the Fc and Fab regions of an antibody, a novel 
antibody display and targeted docking system can be expressed and optimized for E. coli and 
biotherapeutics. 
 Specifically, in this work, I make use of the AIDA surface display system in 
combination with Protein G. Protein G is an immunoglobulin binding protein derived from 
bacterial cell surfaces; it selectively binds the antibody’s Fc region, leaving the Fab region 
free to interact with and bind antigen87; importantly, the Protein G-Fc binding stability is 
aided by hydrogen bonds88. Researchers demonstrated Streptococci Protein G’s ability to bind 
high amounts of human IgG antibody in various buffers ranging from pH 4-989. Naturally, in 
the human body, the Fc receptors form a critical link between the humoral and cellular 
immune response, specifically aiding effector cell functions90. Separately, the AIDA surface 





and peptides to be displayed on the outer surface of bacteria. The use of Protein G as a 
surface exposed vehicle for the assembly of targeting antibodies will naturally depend on the 
binding characteristics between the antibody and the protein G and how these might function 
in the GI tract. 
Using AIDA to surface display Protein G, outlined in Figure 23, allows the 
engineered bacteria to be loaded with an antibody to target the disease-specific up-regulated 
antigen and dock at the site for biotherapeutic release. The approach I am using utilizes and 
optimizes nature’s methods of protein engineering and antibody display. Optimization 
requires that the engineered E. coli uniformly and highly display Protein G on the outer 
surface in a time-efficient manner and without introducing significant metabolic burden. 
 
Figure 23 – AIDA1 surface displaying Protein G. The autotransporter AIDA  consists of a signal peptide at the N 
terminus, one or more domains for transport, and an autotransporter structure at the C terminus. The 
autotransporter domain forms after translocation through the β-sheet barrel within the outer membrane. The N-
terminally attached Protein G is translocated to the surface through this porin-like barrel54. The Fc region of the 
antibody binds the surface-displayed Protein G. 
4.1.2 Microbial Transglutaminase 
 Biologics engineered and expressed in E. coli are often purified and introduced into a 





engineered bacteria as biotherapeutic delivery vehicles themselves14,77,86,91. While Yu et al. 
have used the conventional approach to express high amounts of stable, recombinant mTG, 
they optimized it for a single-purpose system – protein purification51. In this chapter, I look to 
combine the therapeutic properties of their recombinant mTG with the engineered 
biotherapeutic E. coli delivery system.  
 The Sn TGase engineered by Yu et al. was synthesized as a precursor protein with a 
preproregion of 82 amino acid residues. This precursor protein allows for higher solubility of 
folded, inactive protein compared to mature (active) mTG without the preproregion. A high 
level of soluble Sn TGase with its N-terminal propeptide fused with thioredoxin was 
expressed in E. coli. Bovine trypsin cleaves the propeptide from the TGase to for mature 
(avtive) TGase. It showed activity over a broad range of pH and temperature; the activity 
levels are equivalent to the authentic mature TGase51. 
 I hypothesize that by utilizing the Sn TGase system in a low copy plasmid under 
H2O2 control, mTG can be made in lower but soluble concentrations for effective therapeutic 
delivery and activation at the wound site; additionally, the H2O2 control allows it to be 
expressed at the therapeutic site without overburdening the metabolic processes in the 
engineered bacteria. 
4.2 Materials and Methods 
4.2.1 Protein G Surface Display 
DNA Manipulation and Growth Conditions. The genetic construct developed in this study 
were assembled using the standard molecular biology protocol65. The vector designed for this 
study was derived from pAIDA-I (low-copy plasmid), which was donated by Larsson53 and 
previously used for covalent surface display of fusions up to 110 kDa in size. Briefly, the 





S62801 was amplified using the primers specified in Table 2. Protein G and pSBP-
mCherry70 (modified from pAIDA-I) were digested with the SalI and XbaI restriction 
enzymes. The protein G and pLacUV5-AIDA1 fragments were ligated using T4 Ligase (New 
England Technologies). Ligations were transformed in E. coli Top10 cells (Invitrogen) and 
plated on LB agar plates supplemented with chloramphenicol (34 µg/mL) and incubated at 
37°C. Plasmid DNA (Figure 24) from each selected clone was isolated for sequencing using 
Qiagen miniprep and analyzed via restriction digestion. The plasmid was then transformed 
into E. coli K-12 wild type (W3110) and E. coli K-12 ΔluxS (LW12) (constructed by Wang et 
al.92). 
 
Figure 24 - Plasmid design of pG-AIDA1. 
Bacteria were grown in LB media supplemented with ampicillin (50 µg/mL) and incubated at 
37°C in a shaker at 250 rpm for all growth experiments. For all overnight inoculations, 
bacteria were grown from glycerol frozen stock; all morning re-inoculations were adjusted 
with sterile media to OD600 0.05. The strain-plasmid nomenclature and shortened names are 





Characterizing and Optimizing Protein G Surface Display. E. coli WT-pG-AIDA1 and 
LW12-pG-AIDA1 were inoculated into 100 mL of LB in 500 mL flasks. Bacteria were 
shaken at 37°C until OD600 ~0.25. After induction, bacteria were split into 50mL flasks, 
induced with 0-1 mM IPTG, and shaken at either 24°C, 30°C, or 37°C. 1mL samples were 
taken at two, four, and six hours. For quantifying Protein G surface display, 1 mL samples 
were pelleted and resuspended in PBS with 5 µg/mL of Dylight488 (green) antibody (Goat 
Anti-Mouse IgG, Jackson Immunoresearch) flow cytometry (FACS). Samples were shaken 
for 30 minutes, washed multiple times, and resuspended in PBS for flow cytometry (FACS 
CantoII, BD Bioscience) analysis to quantify Protein G-antibody surface display expression. 
2µL samples were taken for simultaneous fluorescent microscopy imaging. BL21(DE3)-
pSBP-mCherry70 served as a negative control and to show that the antibody had no non-
specific binding. For data analysis, technical and biological duplicate data were obtained. 
Statistical Analysis. For most experiments, one-way ANOVA using a multiple comparisons' 
Tukey-Kramer post-test were performed using Matlab (version R2015a). α values of 0.05 
were used to indicate statistical significance. Data are reported as mean values and standard 
deviation of the error, unless otherwise stated. 
4.2.2 Microbial Transglutaminase 
DNA Manipulation and Growth Conditions. The genetic constructs developed in this study 
were assembled using the standard molecular biology protocol65 and Gibson Assembly 
protocol93. Briefly, the oxyR-poxyS and Trx–proTGase genes were amplified using the 
primers specified in Table 2. oxyR/S and pST39 (low-copy plasmid) were digested (1 µg 
each) with the NsiI and XbaI restriction enzymes. The fragments were ligated using T4 
Ligase (New England Technologies). Ligations were transformed in E. coli Top10 cells 





incubated at 37°C. Plasmid DNA from each selected clone was isolated for sequencing using 
Qiagen miniprep and analyzed via restriction digestion. For amplifying pST39-oxyR/S, the 
Gibson primers were designed to have a minimum 15 base pair overlap with the base pairs 
flanking the insert site. Six histidine residues were added to the beginning of SNTGA (TGase, 
1562 base pairs). The pST39-oxyR/S and Trx–proTGase fragments (1:2 ratio) were ligated 
with Gibson Assembly Master Mix following the Gibson Assembly protocol and 
subsequently transformed into chemically-competent NEB 5-alpha E. coli. Plasmid DNA 
(Figure 25) from each selected clone was isolated for sequencing using Qiagen miniprep. 
The plasmid was transformed into E. coli K-12 (W3110). Additionally, as a positive control, 
the pET32aΔ-SNTGA plasmid (provided by Dr. Ming-Te Yang)51 was transformed into E. 
coli K-12 (W3110). 
 
Figure 25 - Plasmid design of H2O2-SNTGA. 



























































































Bacteria were grown in LB media supplemented with ampicillin (50 µg/mL) and 
incubated at 37°C in a shaker at 250 rpm for all growth experiments. For all overnight 
inoculations, bacteria were grown from glycerol frozen stock; all morning re-inoculations 
were adjusted with sterile media to OD600 0.05. The strain-plasmid nomenclature and 
shortened names are listed in Table 2. 
Microbial Transglutaminase Expression and Purification. E. coli WT-SNTGA and WT-
H2O2-Trx-proTGase were grown overnight, reinoculated into 50 mL of LB in 250 mL flasks, 
and shaken at 37°C until OD600 ~0.5. Cells were induced with either 0.5mM IPTG or 300 µM 
H2O2 at 24°C or 24°C, 250rpm for 6, 12, and 18 hours and then centrifuged at 4°C, 12,000 rcf 
for 10 minutes. Bacterial pellets were resuspended with 200 µL BugBuster (BugBuster HT, 
EMD Millipore) and protease inhibitor (HALT Protease Inhibitor Cocktail (100x), Fisher 
Scientific). Cell suspensions were shaken at 24°C, 150 rpm for 1 hour. Insoluble cell debris 
were removed by centrifugation at 4°C, 12,000 rcf for 20 minutes and soluble fractions were 
transferred to new tubes.  
His6-tagged mTG (Trx-proTGase) was purified using TALON Metal Affinity Resin 
(Clontech Laboratories). Briefly, resin was washed with 10mM imidazole for protein binding. 
The resin was pelleted in a swinging-bucket rotor at 4°C, and the supernatant was discarded. 
The supernatant was added to the resin, vortexed, and shaken for 20 min. at room 
temperature. The resin was pelleted, and the supernatant was discarded. The resin was 
washed three times with PBS in an ice bath, shaking for 20 minutes per wash. Trx-proTGase-
His6 bound to the resin was eluted with 300 µL of 250mM imidazole. The elution was briefly 
vortexed and centrifuged. The supernatant from each sample was collected, and protein 





Pre-stained ladder (PageRuler Plus Prestained Protein Ladder, ThermoFisher 
Scientific) and 25 µL of boiled samples were loaded into 12% SDS-PAGE gels (Bio-Rad). 
The SDS-PAGE gel was stained overnight with Coomassie Blue and destained (45% 
methanol, 10% glacial acetic acid).  The gel image was obtained using AlphaImager HP. 
Microbial Transglutaminase Activity Assay. To activate the transglutaminase, each sample 
was incubated with a 1:100 dilution of trypsin (0.25% Trypsin-EDTA, Life Technologies) at 
4°C, 24°C, 30°C, and 37°C overnight. The colorimetric hydroxamate procedure by Sigma-
Aldrich, modified from Folk and Cole94, using N-α-carbobenzoxy-L-glutaminyl-glycine 
(CBZ-Gln-Gly) as a substrate was used for determination of TGase activity. 100 μL of the 
reaction mixture (2 mL of 0.1 M Tris–acetate buffer (pH 6.0), 5 mL of 200 mM 
hydroxylamine and 20mM glutathione-reduced form, and 120 mg of CBZ-Gln-Gly; per 
10mL total volume), and 15 μL of enzyme solution, was incubated at 37°C for 10 min. The 
reaction was stopped by adding 250 μL of 12% (v/v) trichloroacetic acid (TCA) and 250 μL 
of 5% (w/v) FeCl3. After centrifugation at 4,000×g for 15 min, the supernatant was collected 
and the absorbance at 525 nm was measured with BugBuster serving as the test blank. L-
Glutamic acid γ-monohydroxamate was used as a standard. One unit of enzyme TGase 
activity was defined as the amount of enzyme which catalyzed the formation of 1 μM 
hydroxamic acid per minute under the assay conditions. For data analysis, technical and 
biological duplicate data were obtained. 
4.3 Results and Discussion 
4.3.1 Characterizing Protein G’s surface display 
 Initial growth and induction studies were carried out to test the surface display 
efficiency of the engineered LW12-pG-AIDA1 cells and whether they exhibited temperature 





strain, growth media, and temperature-dependent surface display of protein Z (a model 
protein) in AIDA. They conducted studies in OmpT mutants to minimize the proteolysis of 
protein Z and maximize surface expression at various temperatures53. For the initial LW12-
pG-AIDA1 studies, I conducted temperature, dose, and time-dependent experiments. In 
Figure 26, I grew cells at 37°C until OD ~0.25; the cultures were split, induced with IPTG, 
and grown at 30°C and 37oC to examine how the temperature and IPTG concentrations affect 
bacterial growth and Protein G-AIDA1 expression over time. In Figure 26-a, I observed 
similar growth rates, regardless of temperature and IPTG concentration.  
I also conducted AF488 antibody-binding experiments to quantitatively and 
qualitatively characterize Protein G surface display efficiency. A more nuanced analysis of 
the FACS data was conducted by quantifying the different levels of fluorescence (Figure 26-
b, c and Figure 27-a) to correlate Protein G surface display with percentage and levels of 
AF488 fluorescence. Gates were set to show either low (Gate 1), high (Gate 2), or very high 
(Gate 3) Protein G-AF488 expression (Figure 27-a). For pG-AIDA1 induced and expressed 
at 30°C (Figure 26-b), there was a statistically significant difference (α = 0.05) between 2 
(60%-65%) and 4-6 hours (~80% and 85%, respectively) induction time. When induced, 
FACS gating analysis (Figure 27-a) showed that the majority of fluorescence was high (103-
104 mean fluorescence units). This indicated that there was efficient and relatively uniform 
amounts of Protein G surface displayed (with AF488 bound) across all cells. However, when 
pG-AIDA1 was induced at 37°C (Figure 26-c), there was overall a statistically significant 
decrease in expression compared to 30°C (Figure 26-b, c). There was a statistically 
significant increase (α = 0.05) in AF488 expression (bound to Protein G) between 2 hours 
(20%-25%) and 4-6 hours (~60% and 70%, respectively) induction time and decrease 





analysis of 37°C showed that the fluorescence was split between low and high amounts of 
bound AF488. This indicated that there was more variable amounts of Protein G surface 
displayed (with AF488 bound) across all cells over time. Additionally, independent of 
temperature, there was little leaky expression (not induced) over time compared to the 
induced samples. There was no dose-dependent response to IPTG induction, regardless of 
temperature; this indicated that only a small concentration of inducer is required to activate 
pG-AIDA1. Overall, similar to the studies conducted by Gustavsson et al.53, I found the 
efficiency to be temperature-dependent but independent of culture media. 
 
Figure 26 – Characterizing effects of temperature on Protein G surface display efficiency. a. Cell growth bar 
chart. b. FACS average percentage of cells with AF488 antibody bound to Protein G. LW12-pG-AIDA1 
were induced with 0-1 mM IPTG, and sampled 2 hours. Tukey-Kramer ANOVA and multiple 
comparisons analyses were performed with α = 0.05. * indicates the samples differed significantly from 
24°C. ϯ indicates the samples differed significantly from 37°C. 
 Simultaneous to the FACS experiments, the samples were also imaged using 
fluorescent microscopy for qualitative analysis. Previously, I had grown and induced pSBP-
mCherry cells as a negative control to show if the AF488 antibody was non-specifically 
binding (Figure 27-c). Fluorescent microscopy paired with the FACS analysis showed that 
with time, the cells more uniformly and highly surface display Protein G at 30°C compared to 
37°C (Figure 26-b, c and Figure 27-d). When not induced samples were imaged, there were 
very few dim (low GFP fluorescence) compared to the number of cells imaged using phase 
contrast (Figure 27-d, 0 mM IPTG). However, when induced samples were imaged using 





time. Confirming and correlating FACS results and previous studies by Gustavsson et al, 
Protein G induction at 30°C showed higher numbers of green cells and brighter cells 









Figure 27 – FACS Histograms of initial Protein G-AIDA1 surface display. a. FACS histogram legend for AF488 
loaded cells. The percentages of non-bound (no surface display) and bound AF488 (to Protein G) on cells are in 
the upper left and right corners, respectively. b. Baseline histogram and control images. The Baseline histogram is 
the 0 hr timepoint for IPTG induction of LW12-pG-AIDA1. Control microscopy images are BL21(DE3)-pLysS-
pSBP-mCherry with AF488 antibody incubation to check for non-specific binding. d. FACS histograms and 





4.3.2 Optimizing Protein G’s surface display 
 In order to further optimize Protein G surface display, I conducted experiments with 
the E. coli K12 wildtype strain, W3110, and tested induction at 24°C for both LW12- pG-
AIDA1 and WT-pG-AIDA1. Additionally, because OmpT cleaves cysteine-rich proteins53, 
and Protein G is not cysteine-rich, it is not necessary to perform the experiments in ompT- 
W3110. In Figure 28, I grew cells at 37°C until OD ~0.25; the cultures were split, induced 
with IPTG, and grown at 24°C (LW12, WT) and 37oC (WT) to examine how the temperature 
and IPTG concentrations affect bacterial growth between strains and optimize Protein G-
AIDA1 expression over time. In Figure 28-a, I observed similar growth rates, regardless of 
strain and IPTG concentration. 
 
Figure 28 – Comparing Protein G surface display efficiency based on temperature and strain. a. Cell growth 
bar chart. b. FACS average percentage of cells with AF488 antibody bound to Protein G. WT-pG-AIDA1 were 
induced with 0-1 mM IPTG at 37°C and sampled every 2 hours. c. FACS average percentage of cells with AF488 
antibody bound to Protein G. LW12-pG-AIDA1 and WT-pG-AIDA1 were induced with 0-1 mM IPTG at 24°C and 
sampled every 2 hours. Tukey-Kramer ANOVA and multiple comparisons analyses were performed with α = 0.05. 





Additional AF488 antibody-binding experiments quantitatively characterized Protein 
G surface display efficiency (Figure 28-b-d). For WT-pG-AIDA1 induced and expressed at 
37°C (Figure 28-b), there was a statistically significant increase (α = 0.05) in expression 
between 2 hours (50%-60%) and 4-6 hours (~70%, respectively) induction time for 0.5 and 
1mM IPTG. Among the samples, there was low, non-uniform expression to high, saturating 
expression of Protein G surface displayed over time; based on the FACS data, significant 
amounts of low antibody binding (Gate 1) per bacteria indicated that low levels of Protein G 
were being surface displayed. 
In addition to induction concentrations and folding time, many proteins are 
temperature-sensitive for proper folding, including mTG. Importantly, when both LW12-pG-
AIDA1 and WT-pG-AIDA1 were tested at 24°C, all induced samples had uniform high 
antibody binding (Figure 28-c, d); this directly correlates to the amount of Protein G surface 
displayed, indicating that uniformly saturating amounts  (> 90% cells with bound, high 
concentration of AF488 per cell) of Protein G was surface displayed from 2-6 hours. 
Additionally, there was very little leaky expression (not induced, < 10% with low levels of 
bound AF488 and Protein G expression) over time at 24°C. There was no dose-dependent 
response to IPTG induction, regardless of temperature; this indicated that only 2 hours and a 
small concentration of inducer (≤ 0.1 mM IPTG) is required to activate pG-AIDA1 and fully 
display Protein G on the outer surface. Similar to the studies conducted by Wang et al.53, I 
found the protein folding and surface display efficiency to be temperature-dependent (24°C 
optimal) but independent of culture media and strain for surface displaying Protein G.  
4.3.2 Engineering microbial transglutaminase under H2O2 control 
 I conducted studies to test Trx-proTGase’s expression and activity under the H2O2 





optimized the process to express and activate Trx-proTGase.51 Compared to these studies, I 
conducted experiments to minimize expression time while maintaining activity. WT-H2O2-
Trx-proTGase was induced with 300 µM H2O2 for 6, 12, and18 hours at 24°C and 37°C to 
determine mTG solubility and activity over time. The purified His6-tagged Trx-proTGase was 
run on an SDS-PAGE gel to confirm purification results (Figure 29). As seen in the plasmid 
rendering (Figure 25), the His6 tag was engineered at the N-terminus of mTG (after the Trx-
pro region). An mTG mixture (provided by Dr. Gregory F. Payne) served as a positive 
control (Figure 29-Lane 3). Similar to Yu et al.51, we observed three bands with our purified 
proteins – Trx-proTGase (~57 kDa), mature TGase (~39 kDa), and Trx-pro region (~18 kDa). 
There was noticeably lower concentrations (≥ 10-fold) of purified protein when incubated at 
37°C, compared to 24°C (0.05-0.2 mg/mL). 
 
Figure 29 – Trx-proTGase SDS-PAGE. Lane 1 is the PageRuler Plus Prestained Ladder. Lane 3 is the mTG 
positive control. Lanes 4-5 are purified SNTGA from 24°C and 37°C inductions, respectively. Lanes 7-8 are 
purified H2O2-Trx-proTGase induced for 6 hours at 24°C and 37°C, respectively. Lanes 10-11 are purified H2O2-
Trx-proTGase induced for 12 hours at 24°C and 37°C, respectively. Lanes 13-14 are purified H2O2-Trx-proTGase 
induced for 18 hours at 24°C and 37°C, respectively. Lanes 2, 6, 9, 12, and 15 are empty. 
 The colormetric activity assay was used to test mTG activity after 16 hour incubation 
with 100:1 ratio of purified H2O2-Trx-proTGase to trypsin to fully cleave the Trx-pro region. 





cleavage at 4°C. H2O2-SNTGase induced at 37°C yielded low activity for cleavage at 4°C. As 
cleavage temperature was increased (24°C, 30°C, and 37°C), activity decreased from 3.0 
U/mg to ~0.5 U/mg. 











6 5.2 0.6 
12 3.0 0.7 
18 1.9 0.7 
37°C 6-18 1.6 0.7 
 
As a control, WT-SNTGA was induced for 18 hours at 24°C; purified SNTGA was cleaved at 
4°C, yielding a specific activity of 17.2 ± 2.4 U/mg enzyme which is comparable to the 
specific activity determined by Yu et al. after extensive optimization.51 Additionally, purified 
SNTGA cleaved at 30°C and 37°C yielded a specific activity of 15.7 ± 0.1 U/mg. 
4.4 Conclusion 
 For efficient and uniform Protein G surface display with AF488 binding, pG-AIDA1 
yielded > 90% uniform, saturating amounts of Protein G surface display within 2 hours at 
24°C, independent of strain design. However, as induction temperature increased, variation of 
surface display increased and percentage of Protein G surface-displayed decreased; lower 
surface-display expression (20-25% LW12, 55-60% WT) was found, and increased time was 
required to achieve > 60% of surface display at 37°C for both WT and LW12. The fast and 
highly efficient Protein G surface display within 2 hours at 24°C allows the pG-AIDA1 
system to be used for both quorum-sensing and non-quorum sensing platforms and 
biotherapeutics. Specifically for wound-healing based biotherapeutics, a human IgG Annexin 





at the wound site. As noted in the previous chapter, the binding between Protein G and a 
targeting antibody (e.g., Annexin 2) would be subject to further study.  Importantly, the 
Annexin 2 is only upregulated at the wound site, as they enhance wound healing via signaling 
pathways and aid the intestinal epithelial cells’ cytoskeleton remodeling19,95.  
Separately, using the H2O2-SNTGase yielded soluble protein in significantly shorter 
time. Yu et al. developed and characterized the SNTGase system was for overexpression and 
optimal activity; however, expressing the H2O2-SNTGase for only 6 hours at 24°C yielded up 
to 0.2 mg/mL of soluble protein, with a reported activity of ~5.5 U/mL. This activity is 3-4-
fold lower compared to the optimized, overexpressed conditions; however, the active mTG 
can aid crosslinking in a time-efficient manner compared to no mTG. Importantly, the lower 
mTG concentrations produced  in our work potentially benefits the therapeutic application, 
since an increased expression of transglutaminase is linked to Celiac disease44,96; additionally, 
the food industry’s increased use of mTG for various processing and manufacturing 
applications96 leads to more questions of health and the complications caused from daily 
mTG consumption.  
Thus, a balance needs to be achieved in the biotherapeutics – low but active mTG 
and delivered only at the targeted site. In conclusion, by lowering the temperature to 24°C 
and reducing the induction concentration and time needed for Protein G surface display, the 
conditions were optimized for mTG and other temperature-sensitive biotherapeutic 






Chapter 5: Single Bacterial System: Motility, Therapeutic 
Expression, and Self Lysis 
 
5.1 Introduction 
 In order to construct a single E. coli biotherapeutic delivery system, the E. coli need 
to release the biotherapeutic at the wound site and subsequently die. Previous studies have 
accomplished this using T4 bacteriophage lytic proteins to lyse E. coli, but this method 
requires toxic inducers for regulation55. Naturally, E. coli trigger the colicin lysis protein E7 
via the SOS response system due to stressful environmental conditions97. More recent studies 
looked to construct synthetic circuits that express E7 in response to arabinose55, 3OC12HSL 
(from P. aeruginosa)14, and the antibiotic mitomycin C58. Therefore, I hypothesize that E7 
lysis can be achieved in the pHW02 system, using H2O2 as a lysis controller. 
 Specifically, in this work, I engineer E7 after CheZ in the pHW02 system for H2O2 
induced lysis. Because the cheZ gene is directly after the promoter and CheZ expression is 
extremely fast, it is possible for the bacteria to pseudotax before E7 lysis expression begins. 
Since E7 lysis occurs by damaging the inner membrane and permeabilizing the outer 
membrane14,58, it allows for protein to be released into the supernatant, including a 
biotherapeutic. I hypothesize if 1whether there is lysis in an H2O2 dose-dependent response, 
2the effects of metabolic burden on lysis, and 3whether mTG can be expressed as a 
therapeutic, released into the supernatant via E7 lysis, and retain activity. To model mTG 
biotherapeutic release and subsequent activity, I used pET32aΔ-SNTGA. 
5.2 Materials and Methods 
DNA Manipulation and Growth Conditions. The E. coli K-12 W3110-ΔcheZ strain 





developed in this study were assembled using the Gibson Assembly protocol93. Briefly, RBS-
E7 gene (170 base pairs, provided by Dr. Matthew Wook Chang) was amplified using the 
Gibson primers specified in  
Table 4. The primers were designed to have a minimum 15 base pair overlap with the base 
pairs flanking the insert site; the reverse primer was designed to remove the end codon after 
cheZ. Separately, 1 µg of pHW02 was digested with the HindIII restriction enzyme. The 
RBS-E7 and pHW02 fragments (5:1 ratio) were ligated with Gibson Assembly Master Mix 
following the Gibson Assembly protocol, with saturating amounts of RBS-E7 added and 
subsequently transformed into chemically-competent NEB 5-alpha E. coli. Plasmid DNA 
(Figure 30) from each selected clone was isolated for sequencing using Qiagen miniprep.  
 
Figure 30 – Plasmid design of pHW02-E7. 
The correct sequence plasmid (no mutations) was transformed into E. coli K-12 cheZ 
knockout strain (HCW01); additionally, plasmid DNA (Figure 30) from each selected E. coli 
clone was isolated for sequencing using Qiagen miniprep, and the clones with no mutations 
were kept in glycerol stocks for the experiments. The same Gibson protocol was followed to 





transformation and sequencing protocols were followed to co-transform pHW02-E7 with 
either pET200-T5-eGFP or pET32aΔ-SNTGA. 
















Primer Name Primer Sequence  
RBS-E7 
(pFZY1-oxyR/S-cheZ) 











































Bacteria were grown in LB media supplemented with either ampicillin (50 µg/mL) or 
ampicillin and kanamycin (50 µg/mL) and incubated at 37°C in a shaker at 250 rpm for all 
growth experiments. For all overnight inoculations, bacteria were grown from glycerol frozen 
stock; all morning re-inoculations were adjusted with sterile media to OD600 0.05. The strain-
plasmid nomenclature and shortened names are listed in  
Table 4. 
E7 Growth Characterization. E. coli HCW01-pHW02-E7 (with pET200-t5-eGFP for two 
plasmid experiments) were inoculated into 200 mL of LB in 1000 mL flasks, and shaken at 
37°C until OD600 ~0.4. Cells were gently pelleted and resuspended in MOPS media (0.5% 
glucose, Teknova) at OD600 0.4 and shaken at 37°C for 10 minutes to allow for metabolic 
adjustment. The bacteria were split into 25 mL samples in 125 mL flasks for lysis induction 
with 0-200 µM H2O2 and shaken at 24°C and 37°C. 1.5 mL samples were taken at 2, 4, and 6 
hours; after sample volumes were removed, the volume was replaced with another dose of 
H2O2. For the 2 and 6 hour timepoints, 20 µL of bacteria was plated on LB agar plates 
supplemented with ampicillin (50 µg/mL) and incubated at 37°C overnight. 
Quantifying E7 Lysis. The cell pellets were resuspended in PBS and stained with 5 µg/mL 
of propidium iodide (PI, Sigma Aldrich) for 10 minutes. PI cannot penetrate the bacterial 
membrane, so only porous bacteria could be stained with PI. Multiple wash steps with PBS 
were performed, and samples were fixed with 4% paraformaldehyde at room temperature, 
shaking for 30 min. Multiple wash steps with PBS were performed. Samples were 
resuspended in PBS and stored in 4°C overnight. For FACS analysis and confocal 
microscopy, technical and biological duplicates were obtained. For phase-contrast 





 For FACS experiments, WT-pFZY1 (unstained), HCW01-pHW02-E7 (dead), and 
HCW01-pHW02 + pET200-T5-eGFP (live, green, 2 plasmid experiments) were controls for 
setting the scattering and laser(s). The FACS PE (red) laser was used to quantify dead cells. 
For the two plasmid bacteria, the FITC (green) laser was used to identify only eGFP. For the 
FACS experiments with eGFP, compensation was performed on the PE (red, dead) laser. 
Compensation accounts for the spectral emission overlap between the two lasers; 
compensation was performed on the single-stained PI control to calculate and subtract the 
green (eGFP) bleed-over into the red (PI) detector (Figure 36-c). This was performed using 
the compensation tool in the BD FACS Diva software. Briefly, the single-stained PI control 
was plotted on a log-log scatter plot; the x-axis was PE fluorescence, and the y-axis was FITC 
fluorescence. 15% FITC fluorochrome spectral overlap into the PE fluorochrome was 
calculated to negate the small percentage of FITC scattering in the log-log plot. 
E7 Supernatant Protein Characterization. Bacteria timepoint samples were gently 
centrifuged to prevent the cells from shearing and releasing protein into the supernatant. 
Uniform amounts of supernatant were filter-concentrated (Amicon Ultra – 0.5 mL, 10 kDA 
cut-off, EMD Millipore). Concentrated samples were boiled with 2x SDS dye. Pre-stained 
ladder (PageRuler Plus Prestained Protein Ladder, ThermoFisher Scientific) and 25 µL of 
boiled samples were loaded into 12% SDS-PAGE gels (Bio-Rad). The SDS-PAGE gel was 
stained overnight with Coomassie Blue and destained (45% methanol, 10% glacial acetic 
acid). The gel image was obtained using the ChemiDoc Touch Imaging System (Bio-Rad). 
Line profile analysis was conducted using FIJI software98 to determine the mean greyscale 
pixel intensity across the protein band. Multiple line measurements across different heights of 
the band were taken to make a total mean intensity. Induced samples \50-200 µM H2O2) were 





Microbial Transglutaminase Expression via Lysis. E. coli HCW01-pHW02-E7 with 
pET32aΔ-SNTGA were inoculated into 200 mL of LB in 1000 mL flasks, and shaken at 
37°C until OD600 ~0.25. Cells were gently pelleted and resuspended in MOPS media (0.5% 
glucose, Teknova) at OD600 0.25 and shaken at 37°C for 10 minutes to allow for metabolic 
adjustment. The bacteria was then induced with 0.5mM IPTG to initiate mTG expression. For 
aerobic conditions, the bacteria was shaken at 24° for 6 hours; for anaerobic conditions, the 
bacteria was placed (without shaking) in an anaerobic chamber (nitrogen, 2% hydrogen) for 6 
hours. After mTG induction for 6 hours, the bacterial culture were  split into 50 mL samples 
in 250 mL flasks for lysis induction with 0 or 200 µM H2O2 and shaken at 24°C and 37°C for 
2 hours. The bacteria samples were gently centrifuged. The supernatant was filter-
concentrated (Amicon Ultra – 15 mL, 3 kDA cut-off, EMD Millipore). mTG was purified 
from the supernatant and tested for activity using the protocols outlined in 4.2.2. 
Statistical Analysis. For most experiments, one-way ANOVA using a multiple comparisons' 
Tukey-Kramer post-test were performed using Matlab (version R2015a). ANCOVA linear 
regression analysis was performed using Prism (Graphpad Prism 7). α values of 0.05 were 
used to indicate statistical significance. Data are reported as mean values and standard 
deviation of the error, unless otherwise stated. 
5.3 Results and Discussion 
5.3.1 Characterizing H2O2-controlled bacterial lysis via E7 using pHW02 
Initial growth studies were carried out to test whether the engineered pHW02-E7 
cells exhibited enhanced lysis in the presence of H2O2. In addition to evaluating whether a 
potential dose response could be obtained, I was interested to find whether lysis increased 
with time and if the bacteria would adapt to survive lysis. In Chapter 2, I had quantified 





temperatures. With the addition of the E7 lysis protein, I conducted growth experiments using 
HCW01-pHW02-E7 (H2O2-mediated oxyS transcription of CheZ and E7). In Figure 31, I 
grew cells at 37°C until OD ~0.4, gently spun down the cells and resuspended them in MOPS 
media; after the cells were shaken for 10-15 minutes for metabolic adjustment, the cultures 
were split, induced with H2O2, and grown at 24°C and 37oC to examine how the temperature 
and H2O2 concentrations affect bacterial growth. Regression analysis indicated that all 
preinduction growth rates were similar (data not shown). Then, analogously, after a short 
transient phase, cultures induced at 24°C all grew at similar rates irrespective of H2O2; 
however, linear regression analysis confirmed that the cultures induced at 37°C significantly 
varied from both the uninduced 37°C culture and all 24°C growth concentrations (Figure 31-
b, c). These results indicate that growth could be occurring at both 24°C and 37°C regardless 






Figure 31 – Effects of H2O2-E7 lysis on cell growth. a. Cell growth bar chart. HCW01-pHW02-E7 growth at 
different levels of H2O2 and induction temperatures over time. b. Post-induction growth curves. HCW01-pHW02-
E7 growth with 0-500 µM H2O2 induction concentrations at 24°C and 37°C. Lines indicated are least squares 
regressed best fits. c. Tabulated specific growth rates. HCW01-pHW02-E7 growth with 0-500 µM H2O2 induction 
concentrations Linear regression analyses are reported as * ϯ with p < 0.05. * indicates the samples differed 
significantly from 24°C. . ϯ indicates the samples differed significantly from 37°C. 
 To quantitatively characterize E7 lysis, I conducted FACS experiments (Figure 32) 
using the same samples from the growth studies. Briefly, HCW01-pHW02-E7 samples were 
stained red with PI and fixed to identify and quantify the cells in which E7 lysis ruptured 
occurred. PI can only penetrate cells through ruptured membranes, not cells with intact 
membranes. WT-pFZY1 and dead HCW01-pHW02-E7 samples were used to set the voltage, 
scattering, and gating (Figure 32-b, c) for live (unstained) versus dead (PI, stained), 
respectively. To ensure lysis, overnight HCW01-pHW02-E7 culture was induced with > 100 
mM H2O2. At H2O2-lysis induction, a baseline dead value was reported at ~30% (Figure 32-
c); as a control, HCW01-pHW02 death (no E7 lysis) also at OD 0.4 was recorded as ~35%. 





H2O2 dose. At 2 hours, I observed a population shift to the right, indicating that an increased 
number of bacteria were dying (Figure 32-d, 37°C shown). However, as time increased, a 
bimodal population emerged, indicating that a population of bacteria were dying, but there 







Figure 32 – FACS Analysis of H2O2-dosing-E7 lysis. a. Average percentage of propidium-iodide (dead) stained 
cells. HCW01-pHW02-E7 were induced with 0-200 µM H2O2, and sampled and dosed every 2 hours. Tukey-
Kramer ANOVA and multiple comparisons analyses were performed with α = 0.05. * indicates the samples 
differed significantly from 24°C. ϯ indicates the samples differed significantly from 37°C. b. FACS histogram 
legend for PI-stained cells. The percentage of PI-stained (dead) cells is in the upper right corner. c. Control and 
Baseline histograms. Control histograms are unstained WT-pHW02 and dead HCW01-pHW02-E7 cells. The 
Baseline histogram is the 0 hr timepoint for HCW01-pHW02-E7 lysis. d. HCW01-pHW02-E7 37°C histogram 
overlay. e. HCW01-pHW02-E7 37°C histograms. 
 In order to observe the effects of lysis on intracellular protein release, the 
supernatants from the growth/FACS experimental samples (0, 2-6 hrs) were concentrated and 
loaded in an SDS-PAGE gel (Figure 33). While there were significantly marked bands 
visible in the WT-pFZY1 (non-lysed) sample, they were distinct, discrete bands (Figure 33-
a, b; Lane 1) similar to the 0 hr sample (Figure 33-a, b; Lane 3), compared to HCW01-





across all sizes. Importantly, when samples were induced at 37°C (Figure 33-b), increased 
levels of protein were visible across all time points; markedly more protein was observed 
after 4 hours (Lanes 8-11, 0-200 µM) and 6 hours (Lanes 12-15, 0-200 µM) compared to 2 
hours (Lanes 4-7, 0-200 µM). These results indicated that despite the bimodal population 
over time and decrease in percentage of dead cells, the intracellular protein was still released 
into the supernatant. 
 
Figure 33 – HCW01-pHW02-E7 cell supernatant SDS PAGE. a. HCW01-pHW02-E7 induced at 24°C. b. 
HCW01-pHW02-E7 induced at 37°C. For a and b, Lane 1 is WT-pFZY1. Lane 2 is the PageRuler Plus Prestained 
Ladder. Lane 3 is the 0 hour timepoint. Lanes 4-7 are the cell surpernatant after 2 hours of induction (0-200 µM 
H2O2). Lanes 8-11 are the cell surpernatant after 2 hours of induction (0-200 µM H2O2). Lanes 12-15 are the cell 
surpernatant after 2 hours of induction (0-200 µM H2O2). b. HCW01-pHW02-E7 + pET200-t5-eGFP samples 
induced at 37°C. Lane 1 is the PageRuler Plus Prestained Ladder. Lane 2 Lanes 3-6 are the cell surpernatant 
after 2 hours of induction (0-200 µM H2O2). Lanes 7-10 are the cell surpernatant after 2 hours of induction (0-





 Additionally, in order to observe and characterize whether the bimodal population 
indicated if cells were still alive, I plated 20 µL of cells from designated induction 
concentrations and times (Figure 34). Despite induction with 200 µM H2O2 for 6 hours at 
24°C and 37°C, all plates grew bacterial lawns. 
 
Figure 34 – HCW01-pHW02-E7 survival. 20 µL of cells from the designated H2O2 induction, temperature, and 
time were plated on LB agar plates (ampicillin, 50 µg/mL) to compare H2O2-induced E7 lysis efficiency. Plates 
were incubated overnight at 37°C. 
5.3.2 Characterizing pHW02-E7 lysis with increased metabolic burden 
In 2.3.5, I examined the motility burden placed on HCW01-pHW02 with a second 
plasmid encoding constitutive protein expression, pET200-t5-eGFP; this addition of a second 
plasmid also conferred reduced H2O2 uptake rates. Using these results, I examined how 
adding pET200-t5-eGFP affected bacterial growth, lysis, and amount of protein release into 
the supernatant when co-expressed with pHW02-E7. The lysis experiments conducted in this 
section (Figure 35) mirror those conducted in 5.3.1. The biological replicates (B.R.1, B.R.2, 
B.R.3) were analyzed separately due to their differences in growth and lysis behaviors over 





were similar (data not shown). Then, analogously, after a short transient phase, B.R.1 and 
B.R.3 cultures induced at 24°C all grew at similar rates irrespective of H2O2; however, linear 
regression analysis confirmed that the B.R.2 cultures induced at 37°C significantly varied 
compared to all 24°C growth concentrations (Figure 35-b; left column). These results 
indicated that lysis could be occurring at both 24°C and 37°C regardless of H2O2 dose and 
with higher efficiency at 24°C, but more analyses were required. Separately, B.R.2 cultures 
induced with 100 and 200 µM H2O2 at 24°C ad 37°C were statistically significantly lower (p 
< 0.05) than uninduced (0 µM H2O2) and 50 µM H2O2 cultures; however, linear regression 
analysis confirmed that the B.R.2 cultures induced at 37°C were significantly higher (p < 
0.05) compared to all 24°C growth concentrations (Figure 35-b; right column). These 
results indicate that with the metabolic burden, dose-dependent and high percentages of lysis 








Figure 35 – Effects of H2O2-E7 lysis on cell growth with increased metabolic burden. a. Cell growth bar chart. 
HCW01-pHW02-E7 + pET200-t5-eGFP growth at different levels of H2O2 and induction temperatures over time. 
b. Cell growth curves following H2O2 addition. Linear regression of biological replicates with 0-200 µM H2O2 
induction concentrations at 24°C and 37°C. Lines indicated are least squares regressed best fits. c. Linear 
regression analyses. Linear regression analyses are reported as * ϯ with p < 0.05. * indicates the samples differed 
significantly from 24°C. ϯ indicates the samples differed significantly from 37°C. Biological replicates were 
analyzed separately. 
 To quantitatively characterize E7 lysis with increased metabolic burden, I conducted 
FACS experiments (Figure 36) using the same samples from the growth studies. Briefly, 
HCW01-pHW02-E7 + pET200-t5-eGFP samples were stained red with PI and fixed to 
identify and quantify the cells in which E7 lysis ruptured occurred. WT-pFZY1, HCW01-
pET200-t5-eGFP, and dead HCW01-pHW02-E7 samples were used to set the voltage, 





unstained), and dead (PE, stained), respectively. As a positive control and to ensure lysis, 
overnight HCW01-pHW02-E7 culture was induced with > 100 mM H2O2. All samples were 
compensated for the green spectal bleedover into the red spectrum; only the dead. At H2O2-
lysis induction, a baseline dead value (0 hr) was reported at ~80% (Figure 36-c). As a 
control, HCW01-pHW02 + pET200-t5-eGFP death (no E7 lysis) also at OD 0.4 was recorded 
as ~55%. These values were markedly higher than just pHW02-E7, possibly due to increased 
metabolic burden and leaky expression of the H2O2 promoter. As time increased, there was a 
statistically signifcant decrease in cell death, regardless of H2O2 dose. At 2 hours, I observed 
a large percentage of the population were dead (70%-80%), regardless of dose, temperature, 
and biological sample (Figure 36-d, e). However, as time increased for B.R.1 and B.R.3, the 
percentage of dead bacteria decreased over time when induced at 37°C, while those induced 
at 24°C remained unchanged (Figure 36-a, d). However, when analyzing B.R.2 results, there 
was a statistically significant decrease in growth and increase in percentage of PI-stained cells 
when induced with 200 µM H2O2 at 24°C ad 37°C. Conversely, while lysis remained high at 
4-6 hours for 24°C induction, lysis decreased at 4-6 hours (0-100 µM H2O2) for 37°C 














Figure 36 – FACS Analysis of H2O2-dosing-E7 lysis with increased metabolic burden. a. Average percentage of 
propidium-iodide (dead) stained cells. HCW01-pHW02-E7 + pET200-t5-eGFP were induced with 0-200 µM 
H2O2, and sampled and dosed every 2 hours. Tukey-Kramer ANOVA and multiple comparisons analyses were 
performed with α = 0.05. * indicates the samples differed significantly from 24°C. ϯ indicates the samples differed 
significantly from 37°C. b. FACS histogram legend for PI-stained cells with eGFP. The percentage of PI-stained 
(dead) cells is in the upper right corner. c. Control and Baseline histograms. Control histograms are unstained 
WT-pHW02, unstained HCW01-pFZY1 + pET200-t5-eGFP, and PI-stained dead HCW01-pHW02-E7 cells. The 
overlaid histogram shows the spectral bleedover of the green into the red which was negated using compensation. 
The Baseline histogram is the 0 hr timepoint for HCW01-pHW02-E7 + pET200-t5-eGFP lysis. d. HCW01-
pHW02-E7 biological replicate 1 histograms. e. HCW01-pHW02-E7 biological replicate 2 histograms. The 
biological replicate histograms show only 0 and 200 µM H2O2 over time. 
 Previously, percent lysis with increased metabolic burden was calculated using PI-
staining and FACS. However, this did not indicate whether the cells were dead and/or 
expressing eGFP. Confocal microscopy was conducted using the same samples as the growth 
and FACS experiments to qualitatively express the presence or absence of PI and/or eGFP. 
Single color controls were used to set the laser (Figure 37-a); cells that were both red and 
green (dead and containing eGFP) looked yellow in the image overlay. B.R.1 images (0, 200 
µM H2O2) reflected the data obtained by FACS, in that over time, there were red and yellow 





portion of the cells were extremely long and red, indicating that they were replicating without 
dividing and eventually dying. 
 
Figure 37 – Confocal microscopy of Biological Replicate 1 lysis. The biological replicate images show only 0 
and 200 µM H2O2 over time. Images were taken from the representative FACS samples. a. Control images and 0 
hr. images. HCW01-pFZY1 + pET200-t5-eGFP is the green single color control. HCW01-pHW02-E7 dead (PI-
stained) is the red single color control. Bacteria both green and red show as yellow in the images. b. Biological 
Replicate 1 images of 0 and 200 µM H2O2 over time. 
On the contrary, when examining B.R.2 images (0, 200 µM H2O2) over time, I observed 





a). Additional microscopy imaging conducted before the B.R.2 samples were fixed showed 
only cell debris with no eGFP fluorescence after 6 hours of induction with 200 µM H2O2.  
 
Figure 38 – Confocal microscopy of Biological Replicate 2 lysis. The biological replicate images show only 0 
and 200 µM H2O2 over time. Images were taken from the representative FACS samples. a. Biological Replicate 2 
images of 0 and 200 µM H2O2 over time. b. 6 hr. phase contrast microscopy of Biological Replicate 2 samples. 
Phase contrast and GFP images were taken at the 6 hr. timepoint for 24°C and 37°C (0 and 200 µM H2O2) 





In order to observe the effects of increased metabolic burden on lysis and 
intracellular protein release, the supernatants from the growth/FACS experimental samples 
(0, 2-6 hrs) were concentrated and loaded in an SDS-PAGE gel (Figure 39). There were 
distinct, discrete bands visible in the WT-pFZY1 (non-lysed) sample (Figure 39-a; Lane 1), 
opposite to the 0 hour sample (Figure 39-b; Lane 2), compared to HCW01-pHW02-E7. For 
samples induced at 24°C (Figure 39-a), after 2 hours (Lanes 3-6, 0-200 µM), I observed 
significant, low levels of protein across all sizes; after 4 hours (Lanes 7-10, 0-200 µM) and 6 
hours (Lanes 11-14, 0-200 µM), the bands appear to be darker, indicating more protein 
release. Importantly, when samples were induced at 37°C (Figure 39-b), increased levels of 
protein were visible across all time points (darker and/or thicker bands); markedly more 
protein was observed after 4 hours (Lanes 8-11, 0-200 µM) and 6 hours (Lanes 11-14, 0-200 
µM). These results indicated that despite the increased metabolic burden and variation 







Figure 39 – B.R.2 HCW01-pHW02-E7 + pET200-t5-eGFP cell supernatant SDS PAGE. a. HCW01-pHW02-E7 
+ pET200-t5-eGFP samples induced at 24°C. Lane 1 is WT-pFZY1. Lane 2 is the PageRuler Plus Prestained 
Ladder. Lanes 3-6 are the cell surpernatant after 2 hours of lysis (0-200 µM H2O2). Lanes 7-10 are the cell 
surpernatant after 2 hours of lysis (0-200 µM H2O2). Lanes 11-14 are the cell surpernatant after 2 hours of lysis 
(0-200 µM H2O2). b. HCW01-pHW02-E7 + pET200-t5-eGFP samples induced at 37°C. Lane 1 is the PageRuler 
Plus Prestained Ladder. Lane 2 is the 0 hour timepoint. Lanes 3-6 are the cell surpernatant after 2 hours of lysis 
(0-200 µM H2O2). Lanes 7-10 are the cell surpernatant after 2 hours of lysis (0-200 µM H2O2). Lanes 11-14 are 
the cell surpernatant after 2 hours of lysis (0-200 µM H2O2). 
 In addition to the FACS analysis, a semi-quantitative analysis was performed to 
determine the mean grayscale intensity across the bands (indicated by the arrow in the SDS-
PAGE images) (Figure 40). When comparing the average band intensity of not induced (-, 0 





response of protein released. However, there was an increase in protein amount with 
increasing time (darker bands) (Figure 40-a, b-24°C). Conversely, at 37°C and with 
increased metabolic burden, there was an H2O2-dose-dependent response to amount of protein 
release over time (darker bands for induced samples) (Figure 40-b-37°C). 
 
Figure 40 – Cell supernatant SDS PAGE analysis. a. HCW01-pHW02-E7 samples induced at 24°C. b. HCW01-
pHW02-E7 + pET200-t5-eGFP samples induced at 24°C. – samples are not induced. + samples are an average of 
the H2O2 induced range (50-200 µM H2O2). Total supernatant protein concentrations are listed below the – and 
+. Total supernatant protein  
Additionally, in order to observe and characterize whether the decreases and 
increases in percent of PI-stained cells indicated if B.R.2 cells were still alive or dead, 
respectively, I plated 20 µL of cells from designated induction concentrations and times 
(Figure 41). Despite induction with 200 µM H2O2 for 2 and 6 hours at 24°C, the plates grew 
bacterial lawns. More importantly, induction with 200 µM H2O2 for 6 hours at 37°C showed 
no bacterial colonies, confirming FACS and confocal results that nearly 100% lysis was 






Figure 41 – HCW01-pHW02-E7 + pET200-t5-eGFP Biological Replicate 2 survival. 20 µL of Biological 
Replicate 2 cells from the designated H2O2 induction, temperature, and time were plated on LB agar plates 
(ampicillin and kanamycin, 50 µg/mL) to compare H2O2-induced E7 lysis efficiency with increased metabolic 
burden. Plates were incubated overnight at 37°C. 
5.3.3 Characterizing mTG biotherapeutic release with the E7 lysis system 
 In 5.3.2, I showed that despite the increased metabolic burden, HCW01-pHW02-E7 
still lysed and released protein into the supernatant. Based on these results and previous 
studies in 4.3.2, I transformed HCW01 with pHW02-E7 and pET32aΔ-SNTGA to test 
whether mTG as a model biotherapeutic could be released into the supernatant and maintain 
its solubility and activity. When SNTGA was induced aerobically and with shaking at 24°C, 
low levels of soluble SNTGA (~1 µg/mL) was purified from the supernatant, regardless of 
H2O2-lysis induction concentration and temperature. Low activity levels of 3.5 U/mg (24°C 
lysis induction) 6.5 U/mg (37°C lysis induction) were calculated. To try to increase mTG 
production and solubility and decrease non-induced cell lysis, I induced SNTGA 
anaerobically, without shaking at 24°C. Although low levels of soluble SNTGA were purified 
from the supernatant (< 5 µg/mL), higher levels of activity were calculated from the H2O2-





37°C induced lysis, respectively, which is more comparable to the activity reported by Yu et 
al.51. 
5.4 Conclusion 
 While HCW01-pHW02-E7 did not result in H2O2-dose-dependent lysis for the single 
plasmid system, initially significant lysis of 60%-70% occurred at both 24°C and 37°C after 2 
hours induction time. However, as time increased, percent lysis decreased, indicating that a 
surviving portion of bacteria were replicating, as seen in the bimodal population FACS 
histograms, and skewing the percent dead calculation, despite repeated H2O2 doses. Despite 
the decrease in percent dead, protein gels showed that a broad range of intracellular proteins 
were being released into the supernatant. When pHW02-E7 was induced with constitutive 
eGFP expression, higher percent lysis occurred after 2 hours of induction. Higher variation 
was observed and calculated between the two biological replicates. However, B.R.2 
expressed a dose-dependent response to 200 µM H2O2, achieving nearly 100% lysis after 6 
hours. Using FACS, confocal microscopy, and agar plates, I observed and confirmed that 
when lysis decreased in the biological replicates, a portion of bacteria were surviving and 
replicating, except for B.R.2 with 200 µM H2O2 doses. Despite the decrease in lysis, 
increased amounts of intracellular proteins were released into the supernatant, compared to 
the single plasmid system. Using these results, I characterized mTG (SNTGA) expression and 
release into the supernatant using pHW02-E7. Using aerobic versus anaerobic mTG induction 
conditions, I was able to purify the mTG and achieve 10.2-12.8 U/mL of activity, comparable 
to the activity calculated by Yu et al.51. Through further optimization, pHW02-E7 can 






Chapter 6: Conclusions 
 
6.1 Results Summary 
In Chapters 2 and 3, the bacterial motility gene CheZ was engineered under H2O2 
control via the OxyR/S gene-promoter system (pHW02) to control bacterial running towards 
H2O2, known as pseudotaxis. I used multiple methods, including standard growth curves, 
qPCR, Western Blot, and H2O2 consumption, to characterize and demonstrate the genotypic 
dose-dependent response. Then, the H2O2 dose-dependent and time-dependent responses and 
pseudotaxis were phenotypically expressed and quantified using transwells, motility plates, 
microscopy tracking, and a microfluidic device. When induced with either low concentrations 
of H2O2 for 10-15 minutes or high concentrations of H2O2 for 5 minutes, HCW01-pHW02 
recovered motility speeds similar to native speeds. Additionally, when pET200-t5-eGFP was 
added to HCW01-pHW02, I characterized and quantified the motility burden placed on the 
bacteria. This simple synthetic H2O2-responsive bacterial running system restored swimming 
motility while only minimally altering native circuitry.  
In Chapter 4, I engineered Protein G, an IgG (antibody) binding domain, with AIDA1 
to display Protein G on the bacterial outer surface. I improved Protein G surface display to 
have high, uniform levels while using low levels of inducer and a short induction time (2 
hours) at 24oC. This allows bacteria to be docked at the target site while minimizing 
metabolic burden and allowing for temperature-sensitive biotherapeutic expression. 
Additionally, I engineered the SNTGA system under H2O2 control in a low copy plasmid. 
Although Yu et al. optimized SNTGA conditions for high protein and activity yields, I 
showed that H2O2-SNTGA could be expressed within 6 hours and have mTG activity at 





Finally, I engineered the E7 lysis gene under H2O2 control in pHW02 for the release 
of intracellular protein into the supernatant and cell death. Using multiple methods, including 
standard growth curves, PI staining with FACS, and SDS PAGE, I characterized and 
demonstrated that lysis was independent of H2O2 induction but sensitive to induction time. 
Further studies characterized lysis with increased metabolic burden; additional methods, 
including confocal microscopy and agar plates, confirmed lysis in the samples and a dose-
dependent response in B.R.2. Finally, pHW02-E7 + pET32aΔ-SNTGA experiments showed 
that mTG, a biotherapeutic for wound healing, can be expressed intracellularly, released into 
the supernatant via E7 lysis, and maintain relatively high amounts of its activity. 
Overall, I was able to show that the engineered HCW01-pHW02 bacteria were able 
to rapidly consume and swim towards the H2O2, rather than away, within 10-45 minutes. 
Importantly, I used physiologically-relevant concentrations of H2O2, 0-300 µM, for the in 
vitro and microfluidic experiments. Separately, I optimized Protein G-AIDA1 surface display 
as a potential biotherapeutic docking system, and expressed mTG relatively quickly (6 hours) 
that retained its activity as a potential wound healing biotherapeutic. Finally, I engineered 
bacterial lysis also under H2O2 control in the already established pHW02 motility system for 
release of intracellular proteins and the biotherapeutic. I developed, characterized, and 
optimized extensive surface display and H2O2 in vitro testing methods to characterize both 
qualitatively and quantitatively the different components of the potential wound-healing 
engineered bacterial system. 
6.2 Challenges and Future Directions 
6.2.1 Microbial Transglutaminase 
 Although I engineered Trx-proTGase under H2O2 control (Chapter 4), the amount of 





transformed with pHW02-E7, the amount of soluble mTG was low (Chapter 5). In order to 
overcome the concentration of mTG and activity issues, I would remove the oxyR/S promoter 
from pST39-OxyR-pOxyS-Trx–proTGase and replace it with the t5 promoter. First, this 
would increase the amount of soluble Trx-proTGase without overburdening metabolic 
function and motility because it is in a low-copy plasmid, compared to pET32a; additionally, 
because E7 can lyse bacteria within 2 hours, this would prevent extreme accumulation of Trx-
proTGase. By increasing the amount of soluble protein, the amount of active protein 
increases, thus reducing the mTG therapeutic crosslinking time. 
6.2.2 Protein G Surface Display 
 I successfully showed that the pG-AIDA1 bacteria highly and uniformly surface 
display Protein G with bound fluorescent antibody at >90% (Chapter 4). However, the 
stability of the bond in vivo was not tested. Potential complications can arise when the 
engineered bacteria are introduced into a mouse or human model, with varying conditions 
throughout the GI tract. Rigorous in vivo testing needs to be done to determine whether the 
antibody stays bound to Protein G. If not, Protein G could be engineered to also covalently 
bind the antibody, thus providing a more robust binding complex. 
 Also, if the bacterial therapeutic is encapsulated, the engineered bacteria could 
continue to grow and divide. This potentially produces the engineered bacteria without site-
specific antibody preloaded. To overcome this, the site-specific antibody can be introduced 
into the liquid suspension inside the encapsulated therapeutic for binding. 
6.2.3 H2O2-controlled E7 Lysis 
 H2O2-controlled E7 lysis exhibited unpredictable results with variable or no 
dependency on H2O2 dose. In order to overcome this, either the oxyR gene needs to be 





increase the copy number of oxyR genes expressed. Through directed evolution of oxyR, in 
combination with a more optimal ribosome binding site, a library of oxyR mutants can be 
expressed and characterized based on repression tightness. This would allow for reduced 
leakiness, increased biotherapeutic expression, and H2O2-specific lysis at the wound site, 
without compromising motility and H2O2-guided pseudotaxis. Alternatively, lysis can instead 
be regulated by a non-native E. coli promoter, such as IL-6, IL-8, or IL-10, which are 
cytokines up-regulated at the wound site during the inflammatory phase19,95,99; this promoter 
would need to be engineered for recombinant expression of a human promoter for E. coli.  
6.2.3 Future Directions 
Once the obstacles described previously are overcome, the entire therapeutic system 
can be engineered in two plasmids to reduce metabolic burden. Then, E7 lysis can be 
characterized with motility in the single engineered bacteria. For in vitro testing, 
TumbleScore motility video experiments can be performed again to qualitatively and 
quantitatively characterize metabolic and motility burdens before lysis. Additionally, the 
static microfluidic device experiments can be repeated to characterize the pseudotaxis 
response. Separately, microfluidic-based experiments can be used to determine the maximum 
distance necessary for the engineered bacteria to sense and swim towards the H2O2 (at 
physiologically relevant levels, ≤ 300 µM). Next, transwells and wound transwell assays can 
be performed with gut epithelial cells to model the engineered bacteria’s response and the 
rapidity in which the bacteria consume the H2O2 over time. Further in vivo tests can look at 
different modes of delivery, i.e. capsules for oral delivery or a cream or patch for dermal 
delivery. While biotherapeutics are still a relatively new concept, by interacting early and 
often with the FDA and the Gut Microbiome Project, biotherapeutics serve as a potential 
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